Gene_set	Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011094 embryonic lethality before implantation, complete penetrance	15/147	1.2931754304889315e-08	6.803395939802269e-05	0	0	6.4379063928410485	116.93542764608904	VCP;RRM1;PCNA;HSBP1;RPA1;PRPF19;SMARCA4;FBL;RAD51;RPS19;NASP;ARPC3;PSMC4;PES1;RUVBL1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011096 embryonic lethality between implantation and somite formation, complete penetrance	20/282	2.712782468277576e-08	7.135974282804164e-05	0	0	4.4745732375774665	77.95917352277337	BTF3;MBD3;UBE2I;SSB;KDM1A;GPX4;PITPNB;SRSF1;BYSL;DRAP1;PTBP1;PSMD7;RAD51;DAD1;POLD1;NUP62;RPL38;TARDBP;KPNB1;MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013292 embryonic lethality prior to organogenesis	18/234	3.9690314855732215e-08	6.960358215200238e-05	0	0	4.85319097306479	82.70885046013021	AHCY;RRM2;GPX4;COX4I1;RPA1;CD3EAP;SARS;MRPL12;EIF2S2;DDOST;GCSH;ATP5B;KARS;PES1;SRPRB;TARDBP;NOP10;ABCF1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011100 preweaning lethality, complete penetrance	47/1400	8.280479934042844e-07	0.0010890901233249848	0	0	2.118071203244705	29.661881563588906	VCP;NDUFB8;RAB5C;AHCY;KDM1A;UQCRB;HDAC1;RPL12;COX4I1;ATP5A1;BCCIP;MRPL12;COX7C;LMNB2;GCSH;ATP5B;RBBP4;MAT2A;PES1;NUP62;RRS1;EIF4H;UQCRFS1;DENR;GOLGA7;RAB2A;HELLS;RRM2;GLRX3;RPA1;CD3EAP;SARS;H13;EIF2S2;UCHL5;DDOST;NUDT21;EIF3M;KARS;MYBBP1A;ARPC3;NHP2;SRPRB;UBA2;SUCLG1;TARDBP;NOP10
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011704 decreased fibroblast proliferation	9/96	2.1821621656311457e-05	0.02296071030677092	0	0	5.9148264984227135	63.481521651813644	POLE4;NPM1;GLRX3;LIG1;DKC1;PSME3;HAT1;YBX1;LYAR
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004028 chromosome breakage	5/26	4.849642878883899e-05	0.04252328530968032	0	0	12.132977432661974	120.52924527968588	NPM1;RPA1;HMGB1;SMC1A;MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003077 abnormal cell cycle	9/115	9.104108725259721e-05	0.06842388000513057	0	0	4.937594294335483	45.94036308088703	YWHAE;POLE4;NPM1;GLRX3;HDAC1;NONO;RPS6;MCM3;MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008866 chromosomal instability	6/52	0.00016669838730014991	0.10962502694826108	0	0	7.279786459597187	63.32922428428952	POLE4;MCM7;LIG1;MCM3;MCM6;MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0012114 absent inner cell mass proliferation	5/42	0.00050973757824842	0.2979699332405485	0	0	7.510890791647888	56.94467866251709	RAD51;POLD1;PRPF19;TARDBP;MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010380 abnormal inner cell mass apoptosis	4/26	0.0007028412916244211	0.369764803523608	0	0	9.70638194612958	70.47201601897042	UBE2I;DAD1;PRPF19;MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011903 decreased hematopoietic stem cell proliferation	2/5	0.0024264097918535394	1.0	0	0	25.236593059936908	151.95817201388263	DKC1;MCM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000352 decreased cell proliferation	9/182	0.002549462459626665	1.0	0	0	3.1199084826845085	18.631696425838786	PTBP1;HELLS;RAD51;PARP1;PSME3;C1QBP;G3BP1;RPA1;PRPF19
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002447 abnormal erythrocyte morphology	6/90	0.003088193990849461	1.0	0	0	4.206098843322819	24.31196142133256	MCM7;DKC1;MCM3;MCM6;MCM2;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008057 abnormal DNA replication	3/20	0.0036813299938514	1.0	0	0	9.463722397476339	53.03925407623337	POLE4;LIG1;MCM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004030 induced chromosome breakage	3/22	0.004858155250703025	1.0	0	0	8.603383997705764	45.83105670638681	POLE4;PARP1;USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002429 abnormal blood cell morphology/development	3/22	0.004858155250703025	1.0	0	0	8.603383997705764	45.83105670638681	UBE2I;LIG1;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011103 embryonic lethality at implantation, incomplete penetrance	2/7	0.004989504775346893	1.0	0	0	18.026137899954936	95.54607692764526	BSG;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011091 prenatal lethality, complete penetrance	13/362	0.005365704127992436	1.0	0	0	2.2657162277567666	11.844547408912685	SMARCE1;KDM1A;MCM7;HDAC1;NOP2;UCHL5;RPS19;MCM3;CCDC86;RPL38;MCM6;TARDBP;MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013293 embryonic lethality prior to tooth bud stage	9/204	0.005393399223619045	1.0	0	0	2.7834477639636295	14.53677706190499	ATP5B;AHCY;GPX4;PES1;COX4I1;SRPRB;SUCLG1;GOLGA7;DDOST
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002123 abnormal definitive hematopoiesis	6/102	0.005708044349592486	1.0	0	0	3.71126368528484	19.17193842891946	LIG1;DKC1;OLA1;RPA1;HMGB3;YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008941 reticulocytopenia	2/8	0.006583273888665925	1.0	0	0	15.772870662460567	79.23064835825892	NPM1;RPS19
MGI_Mammalian_Phenotype_Level_4_2019	MP:0030049 prominent forehead	2/8	0.006583273888665925	1.0	0	0	15.772870662460567	79.23064835825892	POLE4;BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006042 increased apoptosis	7/139	0.006775790836939452	1.0	0	0	3.177268910423712	15.868549273677967	PTBP1;NPM1;KDM1A;RPS19;PARP1;MCM3;TFAM
MGI_Mammalian_Phenotype_Level_4_2019	MP:0012431 increased lymphoma incidence	6/107	0.007176893924169289	1.0	0	0	3.5378401485892863	17.46592266497767	POLE4;LIG1;MSH2;POLD1;MCM3;RPA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001674 abnormal germ layer development	3/26	0.007828432080420332	1.0	0	0	7.279786459597187	35.30691361942399	GPX4;DAD1;WLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004023 abnormal chromosome number	2/9	0.008376026623286738	1.0	0	0	14.020329477742727	67.05056609742121	HELLS;MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003269 colon polyps	2/9	0.008376026623286738	1.0	0	0	14.020329477742727	67.05056609742121	MSH2;MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001695 abnormal gastrulation	4/51	0.008621331323948942	1.0	0	0	4.948351580379786	23.522067224832448	DRAP1;PTBP1;KDM1A;NONO
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001730 embryonic growth arrest	10/263	0.009502479698561031	1.0	0	0	2.3989156901080717	11.169837218060259	FBL;NPM1;RAD51;KDM1A;NASP;PSMC4;HDAC1;PES1;RPL38;WLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001698 decreased embryo size	16/537	0.012149519039050942	1.0	0	0	1.879820712099584	8.290884763921342	NPM1;LIG1;GPX4;GLRX3;OLA1;YBX1;POLE4;PTBP1;RAD51;NASP;DAD1;C1QBP;TMED2;TCEA1;RPL38;MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011111 lethality during fetal growth through weaning, complete penetrance	2/11	0.012531972455833349	1.0	0	0	11.471178663607686	50.237706954990514	KDM1A;YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0020234 decreased basal metabolism	2/11	0.012531972455833349	1.0	0	0	11.471178663607686	50.237706954990514	UQCRFS1;NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003789 increased osteosarcoma incidence	2/12	0.014882307434907488	1.0	0	0	10.515247108307047	44.243766477907435	MSH2;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004965 inner cell mass degeneration	3/33	0.015146064825484688	1.0	0	0	5.735589331803843	24.032202628389694	SSB;POLD1;MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001658 increased mortality induced by gamma-irradiation	3/34	0.016420805221799516	1.0	0	0	5.566895527927259	22.875521267807283	GPX4;PARP1;USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002020 increased tumor incidence	6/130	0.017564926040030415	1.0	0	0	2.9119145838388745	11.76952546639452	LIG1;MSH2;DKC1;POLD1;MCM3;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011092 embryonic lethality, complete penetrance	12/381	0.01900371936546949	1.0	0	0	1.987133311806056	7.875248889234358	NPM1;EIF3M;SSB;RPS19;MYBBP1A;GPX4;HDAC1;ACTL6A;RPL38;YBX1;TARDBP;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001685 abnormal endoderm development	3/36	0.019145585912515164	1.0	0	0	5.257623554153524	20.79749258978333	PTBP1;HSBP1;WLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000828 abnormal fourth ventricle morphology	2/14	0.020096712652391317	1.0	0	0	9.013068949977468	35.2158542309606	POLE4;UCHL5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009687 empty decidua capsularis	2/14	0.020096712652391317	1.0	0	0	9.013068949977468	35.2158542309606	BTF3;GPX4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010087 increased circulating fructosamine level	2/14	0.020096712652391317	1.0	0	0	9.013068949977468	35.2158542309606	RAB5C;FAM53B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004809 increased hematopoietic stem cell number	3/37	0.020595942121096673	1.0	0	0	5.115525620257482	19.861852879205536	POLE4;NPM1;MCM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000873 thin external granule cell layer	2/15	0.02294883629513588	1.0	0	0	8.412197686645637	31.75173964126585	CCND2;LMNB2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004014 abnormal uterine environment	2/15	0.02294883629513588	1.0	0	0	8.412197686645637	31.75173964126585	ARHGDIA;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002957 increased intestinal adenocarcinoma incidence	2/16	0.02595651826896012	1.0	0	0	7.886435331230284	28.79599775402482	MSH2;POLD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002718 abnormal inner cell mass morphology	3/41	0.026984947760980555	1.0	0	0	4.616449949988459	16.676814920831163	UBE2I;ARPC3;DAD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003984 embryonic growth retardation	16/595	0.028482070618429386	1.0	0	0	1.6965776847016412	6.037238592107575	RRM1;LIG1;HDAC1;OLA1;YBX1;COX7C;UCHL5;PTBP1;EIF3M;DAD1;C1QBP;G3BP1;EIF4H;TMED2;RPL38;GOLGA7
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004815 abnormal somatic hypermutation frequency	2/17	0.029114143729149805	1.0	0	0	7.422527370569679	26.24999951071361	PCNA;MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000321 increased bone marrow cell number	3/44	0.0323915542478991	1.0	0	0	4.301691998852882	14.754190829620061	NPM1;LIG1;TOMM5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003207 decreased cellular sensitivity to gamma-irradiation	2/18	0.032416235743651316	1.0	0	0	7.010164738871364	24.038527013634912	HELLS;HINT1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004619 caudal vertebral fusion	2/18	0.032416235743651316	1.0	0	0	7.010164738871364	24.038527013634912	POLE4;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004045 abnormal cell cycle checkpoint function	3/45	0.0343099281137421	1.0	0	0	4.206098843322819	14.18431342718148	PARP1;PSME3;SMC1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009719 reduced cerebellar foliation	2/19	0.03585745237899185	1.0	0	0	6.641208699983398	22.103296409493502	POLE4;KHDRBS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010300 increased skin tumor incidence	2/21	0.043136549434716114	1.0	0	0	6.0087126333183125	18.887694916672274	MSH2;POLD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001883 increased mammary adenocarcinoma incidence	2/21	0.043136549434716114	1.0	0	0	6.0087126333183125	18.887694916672274	DKC1;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011097 embryonic lethality between somite formation and embryo turning, complete penetrance	4/85	0.04618588784286973	1.0	0	0	2.969010948227872	9.129949112645068	GPX4;POLD1;EIF2S2;SF1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004086 absent heartbeat	2/22	0.046964395274248574	1.0	0	0	5.735589331803843	17.541528601734935	HSP90AB1;TMED2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003448 abnormal tumor morphology	2/22	0.046964395274248574	1.0	0	0	5.735589331803843	17.541528601734935	MSH2;SF1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001697 abnormal embryo size	8/251	0.0473422214155496	1.0	0	0	2.0108839091583195	6.133905264829719	RANBP1;RRM1;COX4I1;EIF4H;GOLGA7;COX7C;HNRNPAB;DDOST
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000428 abnormal craniofacial morphology	6/165	0.04801908819804556	1.0	0	0	2.294235732721537	6.965659136981253	POLE4;RANBP1;KARS;HAT1;G3BP1;YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004957 abnormal blastocyst morphology	2/23	0.05091129106145748	1.0	0	0	5.48621588259498	16.336143473907686	ARPC3;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008128 abnormal brain internal capsule morphology	2/23	0.05091129106145748	1.0	0	0	5.48621588259498	16.336143473907686	CANX;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000601 small liver	4/88	0.05130595132257276	1.0	0	0	2.8677946659019216	8.517202533259166	KDM1A;LIG1;BSG;YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004258 abnormal placenta size	2/24	0.05497252770098663	1.0	0	0	5.257623554153524	15.251954336935961	RANBP1;COX7C
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005031 abnormal trophoblast layer morphology	3/56	0.059128243147902486	1.0	0	0	3.3799008562415502	9.558517061554408	HSP90AB1;POLD1;RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002024 increased T cell derived lymphoma incidence	3/56	0.059128243147902486	1.0	0	0	3.3799008562415502	9.558517061554408	POLE4;MSH2;POLD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011098 embryonic lethality during organogenesis, complete penetrance	16/656	0.059249277708949874	1.0	0	0	1.538816649996153	4.348698452885204	NPM1;HSP90AB1;KDM1A;NDUFA5;GLRX3;HDAC1;SMARCA4;PTBP1;DAD1;C1QBP;POLD1;TFAM;TMED2;RPL22L1;WLS;SF1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013504 increased embryonic tissue cell apoptosis	4/94	0.06243668389039515	1.0	0	0	2.68474394254648	7.446411956462287	POLE4;NPM1;DAD1;MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009781 abnormal preimplantation embryo development	2/26	0.06341977728743703	1.0	0	0	4.85319097306479	13.385001318062404	MYBBP1A;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000600 liver hypoplasia	3/59	0.06702753698072281	1.0	0	0	3.208041490669946	8.67021893059767	LIG1;TCEA1;YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009429 decreased embryo weight	2/27	0.06779695454836354	1.0	0	0	4.673443159247576	12.577347836010599	POLE4;HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004207 increased squamous cell carcinoma incidence	2/28	0.072270796330502	1.0	0	0	4.506534474988734	11.840176453008961	MSH2;POLD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002590 increased mean corpuscular volume	5/142	0.07581296282344216	1.0	0	0	2.2215310792197984	5.730408289538982	GCSH;NPM1;RPA1;FAM53B;TMEM165
MGI_Mammalian_Phenotype_Level_4_2019	MP:0012142 absent amniotic cavity	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	RAD51
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006167 eyelid edema	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006425 absent Mullerian ducts	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000151 absent ribs	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010091 decreased circulating creatine kinase level	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	PES1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010031 abnormal cranium size	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013992 persistent dorsal ophthalmic artery	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013855 absent celiac artery	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013858 abnormal azygos vein topology	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0020421 increased freezing behavior	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	RAB2A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009797 abnormal mismatch repair	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011877 absent liver	1/5	0.07678443177463125	1.0	0	0	12.618296529968454	32.38805515009513	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002663 absent blastocoele	2/29	0.07683716118036331	1.0	0	0	4.351136734471881	11.165307892177287	PTBP1;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008014 increased lung tumor incidence	2/29	0.07683716118036331	1.0	0	0	4.351136734471881	11.165307892177287	MSH2;POLD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011968 decreased threshold for auditory brainstem response	2/29	0.07683716118036331	1.0	0	0	4.351136734471881	11.165307892177287	FAM53B;BZW1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013501 increased fibroblast apoptosis	2/30	0.08149201388085803	1.0	0	0	4.206098843322819	10.545742387922193	NPM1;DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001935 decreased litter size	9/331	0.0819983000078294	1.0	0	0	1.7154783802071916	4.290508805531772	POLE4;YWHAE;PARP1;GPX4;EIF4H;BAZ1B;FKBP4;EIF2S2;RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008935 decreased mean platelet volume	2/31	0.08623142318910418	1.0	0	0	4.070418235473695	9.975457940709145	UQCRQ;TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009278 abnormal bone marrow cell physiology	2/31	0.08623142318910418	1.0	0	0	4.070418235473695	9.975457940709145	LIG1;DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009431 decreased fetal weight	3/66	0.08719138511154484	1.0	0	0	2.8677946659019216	6.996414532664428	POLE4;HELLS;OLA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004607 abnormal cervical atlas morphology	2/32	0.09105155952069358	1.0	0	0	3.943217665615142	9.449248204953683	RPL38;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002416 abnormal proerythroblast morphology	2/32	0.09105155952069358	1.0	0	0	3.943217665615142	9.449248204953683	NPM1;MCM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009302 increased renal fat pad weight	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011243 decreased fetal derived definitive erythrocyte cell number	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	MCM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0012129 failure of blastocyst formation	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	MYBBP1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004963 abnormal blastocoele morphology	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011372 decreased renal tubule apoptosis	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003330 abnormal auditory tube	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0014114 abnormal cognition	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008404 increased cellular sensitivity to methylmethanesulfonate	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	SMC1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002789 male pseudohermaphroditism	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001727 abnormal embryo implantation	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000664 small prostate gland anterior lobe	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0012184 absent paraxial mesoderm	1/6	0.0914210313838074	1.0	0	0	10.515247108307047	25.155412453460716	DRAP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001577 anemia	7/248	0.10061887421091198	1.0	0	0	1.7808079780197414	4.089474905241986	POLE4;NPM1;LIG1;DKC1;C1QBP;TCEA1;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010068 decreased red blood cell distribution width	2/34	0.10091919014349048	1.0	0	0	3.71126368528484	8.51154269801072	FAM53B;DDOST
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003720 abnormal neural tube closure	4/112	0.10265365914172092	1.0	0	0	2.253267237494367	5.129325122521234	RANBP1;COX4I1;YBX1;DDOST
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000692 small spleen	4/113	0.10517068496800698	1.0	0	0	2.2333268194634432	5.029833176095304	POLE4;HELLS;KDM1A;DDOST
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013279 increased fasting circulating glucose level	4/113	0.10517068496800698	1.0	0	0	2.2333268194634432	5.029833176095304	CCND2;RCC2;TARDBP;COX7C
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000853 absent cerebellar foliation	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	LMNB2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003708 binucleate	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	GLRX3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009387 abnormal epidermal pigmentation	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	RPS19
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009277 increased brain tumor incidence	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006411 upturned snout	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009762 abnormal mitotic spindle assembly checkpoint	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005527 increased renal glomerular filtration rate	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011707 impaired fibroblast cell migration	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	ARPC3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0012284 increased sternebra number	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008575 increased circulating interferon-beta level	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	LSM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010924 abnormal osteoid morphology	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009222 increased uterus tumor incidence	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009656 delayed chorioallantoic fusion	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	TMED2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013996 abnormal vertebral artery origin	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0014115 cognitive inflexibility	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010384 increased renal carcinoma incidence	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009420 skeletal muscle endomysial fibrosis	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005502 abnormal renal/urinary system physiology	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005034 abnormal anus morphology	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0012504 increased forebrain apoptosis	1/7	0.10582630556130854	1.0	0	0	9.013068949977468	20.24295768965723	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001792 impaired wound healing	2/35	0.10595951397313348	1.0	0	0	3.6052275799909865	8.092647864727564	ARPC3;NONO
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000358 abnormal cell morphology	4/114	0.10771566133483024	1.0	0	0	2.213736233327799	4.932780539261785	DKC1;ARPC3;RPS6;YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000245 abnormal erythropoiesis	4/117	0.11551519388603165	1.0	0	0	2.156973765806573	4.655511248888375	LIG1;MCM3;HMGB3;TCEA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005170 cleft upper lip	2/37	0.1162359537087768	1.0	0	0	3.4103504135049887	7.339527905624001	RPL38;RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001349 excessive tearing	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002212 abnormal secondary sex determination	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009828 increased tumor latency	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0012062 small tail bud	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	TMED2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004600 abnormal vertebral transverse process morphology	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010563 increased heart right ventricle size	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002174 abnormal gastrulation movements	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	DRAP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003124 hypospadia	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005188 small penis	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010639 altered tumor pathology	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	IDH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004604 abnormal vertebral pedicle morphology	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004759 decreased mitotic index	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	YWHAE
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008737 abnormal spleen physiology	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	LIG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001214 skin hyperplasia	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000923 abnormal roof plate morphology	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000168 abnormal bone marrow development	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	KHDRBS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002715 decreased glycogen catabolism rate	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	HMGB1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003426 pulmonary interstitial fibrosis	1/8	0.12000389833556176	1.0	0	0	7.886435331230284	16.72106506780814	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000783 abnormal forebrain morphology	4/119	0.12084885572481285	1.0	0	0	2.120722105877051	4.481541002433702	RANBP1;H13;LMNB2;DDOST
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003702 abnormal chromosome morphology	2/38	0.1214654515227743	1.0	0	0	3.320604349991698	7.000250394299668	HELLS;KIF22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011703 increased fibroblast proliferation	2/39	0.1267515356937815	1.0	0	0	3.2354606487098603	6.682929776452227	HINT1;NONO
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002085 abnormal embryonic tissue morphology	5/167	0.12689201325349198	1.0	0	0	1.8889665464024632	3.8996181332612236	RAD51;GPX4;DAD1;PES1;MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003717 pallor	6/218	0.13381850561160155	1.0	0	0	1.7364628252250167	3.4924970326907068	NPM1;LIG1;COX4I1;MCM3;YBX1;COX7C
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010901 abnormal pulmonary alveolar parenchyma morphology	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005356 positive geotaxis	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	CANX
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003763 abnormal thymus physiology	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	LIG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011197 abnormal proamniotic cavity morphology	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	DAD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001014 absent superior cervical ganglion	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004757 abnormal distal convoluted tubule morphology	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008573 increased circulating interferon-alpha level	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	LSM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011187 abnormal parietal endoderm morphology	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	DAD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013826 absent hypoglossal canal	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004653 absent caudal vertebrae	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004806 absent germ cells	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	PCNA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004614 caudal vertebral transformation	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0030927 decreased telomere length	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010334 pleural effusion	1/9	0.13395739671846146	1.0	0	0	7.010164738871364	14.092067749878078	IVNS1ABP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010955 abnormal respiratory electron transport chain	2/41	0.13748117686458758	1.0	0	0	3.077633299992306	6.106850093950393	C1QBP;UQCRFS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000242 impaired fertilization	3/81	0.1375267104364502	1.0	0	0	2.336721579623788	4.635908687980981	GPX4;ARHGDIA;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003051 curly tail	3/82	0.14117841050662314	1.0	0	0	2.3082249749942294	4.51888327854461	POLE4;TCEA1;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001919 abnormal reproductive system physiology	2/42	0.1429187970947895	1.0	0	0	3.0043563166591563	5.844911108593969	ARHGDIA;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004652 small caudal vertebrae	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006262 increased testis tumor incidence	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	SF1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008009 delayed cellular replicative senescence	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	NONO
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011191 increased embryonic epiblast cell apoptosis	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	RAD51
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003387 aorta coarctation	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0012176 abnormal head development	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	HDAC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004651 increased thoracic vertebrae number	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0014023 abnormal intestine placement	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008011 intestine polyps	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009859 eye opacity	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003701 elevated level of mitotic sister chromatid exchange	1/10	0.14769033146960184	1.0	0	0	6.309148264984227	12.067113893917599	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000852 small cerebellum	3/84	0.14857783110045056	1.0	0	0	2.253267237494367	4.296183737911694	POLE4;CCND2;EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002966 decreased circulating alkaline phosphatase level	3/85	0.1523238792718889	1.0	0	0	2.226758211170904	4.190193892049247	GCSH;ATPIF1;USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004073 caudal body truncation	2/44	0.15392539454460827	1.0	0	0	2.8677946659019216	5.36646757947189	DAD1;TMED2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005324 ascites	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	IVNS1ABP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008023 abnormal styloid process morphology	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004601 abnormal vertebral spinous process morphology	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011395 decreased fetal cardiomyocyte proliferation	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	YWHAE
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009770 abnormal optic chiasm morphology	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004250 tau protein deposits	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	HSPA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0030934 decreased primordial germ cell proliferation	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	EIF2S2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008526 decreased cranium width	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013985 abnormal umbilical vein topology	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013936 abnormal thymus topology	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013977 symmetric azygos veins	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009308 increased adenocarcinoma incidence	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	LIG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011278 increased ear pigmentation	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	RPS19
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005460 abnormal leukopoiesis	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	HMGB3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010556 thin ventricle myocardium compact layer	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	YWHAE
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009648 abnormal superovulation	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002050 increased pheochromocytoma incidence	1/11	0.1612061780406288	1.0	0	0	5.735589331803843	10.467858470489997	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000897 abnormal midbrain morphology	2/47	0.17072325964221782	1.0	0	0	2.68474394254648	4.745852468250408	RANBP1;UCHL5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002674 abnormal sperm motility	2/47	0.17072325964221782	1.0	0	0	2.68474394254648	4.745852468250408	GPX4;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008058 abnormal DNA repair	2/47	0.17072325964221782	1.0	0	0	2.68474394254648	4.745852468250408	PARP1;DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005249 abnormal palatine bone morphology	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009266 abnormal mesendoderm development	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	DRAP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010439 abnormal hepatic vein morphology	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011636 disorganized mitochondrial cristae	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	TFAM
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010602 abnormal pulmonary valve cusp morphology	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010933 decreased trabecular bone connectivity density	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011167 abnormal adipose tissue development	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	PCNA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002053 decreased incidence of induced tumors	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	EIF2S2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004153 increased renal tubule apoptosis	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010363 increased fibrosarcoma incidence	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011452 decreased susceptibility to dopaminergic neuron neurotoxicity	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008477 decreased spleen red pulp amount	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009836 abnormal sperm principal piece morphology	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	GPX4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000597 delayed hepatic development	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	OLA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011200 abnormal extraembryonic coelom morphology	1/12	0.17450835725876654	1.0	0	0	5.257623554153524	9.178667959443157	DAD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000313 abnormal cell death	2/48	0.17638907615311694	1.0	0	0	2.6288117770767614	4.56115421634229	GLRX3;SMC1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000841 abnormal hindbrain morphology	2/48	0.17638907615311694	1.0	0	0	2.6288117770767614	4.56115421634229	RANBP1;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002075 abnormal coat/hair pigmentation	5/189	0.18183263103414626	1.0	0	0	1.6690868425884198	2.845239972473834	HELLS;ARF2;MMGT2;RCC2;MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000458 abnormal mandible morphology	2/49	0.18208408759465888	1.0	0	0	2.575162557136419	4.386240079450797	HAT1;YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008973 decreased erythroid progenitor cell number	2/49	0.18208408759465888	1.0	0	0	2.575162557136419	4.386240079450797	LIG1;DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010420 muscular ventricular septal defect	3/93	0.1832947252992609	1.0	0	0	2.0352091177368474	3.4530576999644333	H13;BAZ1B;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0012136 absent forebrain	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003139 patent ductus arteriosus	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004418 small parietal bone	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009820 abnormal liver vasculature morphology	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003963 abnormal corticosterone level	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	MYG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011105 embryonic lethality between implantation and placentation, incomplete penetrance	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	KDM1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005189 abnormal anogenital distance	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010574 aorta dilation	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	LSM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001862 interstitial pneumonia	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	BSG
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002858 abnormal posterior semicircular canal morphology	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008249 abnormal common lymphocyte progenitor cell morphology	1/13	0.187600236285976	1.0	0	0	4.85319097306479	8.121533525312682	HMGB3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004200 decreased fetal size	4/142	0.18894916469706272	1.0	0	0	1.7772248633758387	2.9613493934477013	POLE4;MCM3;YBX1;BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002687 oligozoospermia	6/244	0.1920596510434284	1.0	0	0	1.5514299012256296	2.5597806371541383	CCND2;CBX3;HSPA4;ARHGDIA;USP1;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004599 abnormal vertebral arch morphology	2/51	0.19355240672651006	1.0	0	0	2.474175790189893	4.063108721187051	RPL38;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004756 abnormal proximal convoluted tubule morphology	2/51	0.19355240672651006	1.0	0	0	2.474175790189893	4.063108721187051	HELLS;DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008470 abnormal spleen B cell follicle morphology	2/51	0.19355240672651006	1.0	0	0	2.474175790189893	4.063108721187051	POLE4;NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002160 abnormal reproductive system morphology	2/51	0.19355240672651006	1.0	0	0	2.474175790189893	4.063108721187051	ARHGDIA;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001696 failure to gastrulate	2/52	0.1993212346338995	1.0	0	0	2.426595486532395	3.9137042255720416	KDM1A;GPX4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000373 belly spot	3/97	0.19936326391008635	1.0	0	0	1.9512829685518231	3.1466909588794936	POLE4;RPS19;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003954 abnormal Reichert's membrane morphology	1/14	0.20048512941488955	1.0	0	0	4.506534474988734	7.242069411865003	PTBP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003845 abnormal decidualization	1/14	0.20048512941488955	1.0	0	0	4.506534474988734	7.242069411865003	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009131 decreased white fat cell number	1/14	0.20048512941488955	1.0	0	0	4.506534474988734	7.242069411865003	PCNA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000228 abnormal thrombopoiesis	1/14	0.20048512941488955	1.0	0	0	4.506534474988734	7.242069411865003	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004142 abnormal muscle tone	1/14	0.20048512941488955	1.0	0	0	4.506534474988734	7.242069411865003	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010490 abnormal inferior vena cava valve morphology	1/14	0.20048512941488955	1.0	0	0	4.506534474988734	7.242069411865003	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011276 increased tail pigmentation	1/14	0.20048512941488955	1.0	0	0	4.506534474988734	7.242069411865003	RPS19
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003646 muscle fatigue	1/14	0.20048512941488955	1.0	0	0	4.506534474988734	7.242069411865003	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000455 abnormal maxilla morphology	2/53	0.20511029483690474	1.0	0	0	2.3808106660317843	3.7716979249613063	YBX1;RBBP7
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003036 vertebral transformation	2/53	0.20511029483690474	1.0	0	0	2.3808106660317843	3.7716979249613063	CBX5;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001712 abnormal placenta development	2/53	0.20511029483690474	1.0	0	0	2.3808106660317843	3.7716979249613063	NPM1;COX7C
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002027 increased lung adenocarcinoma incidence	2/53	0.20511029483690474	1.0	0	0	2.3808106660317843	3.7716979249613063	POLD1;MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001412 excessive scratching	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004739 conductive hearing loss	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008439 abnormal cortical plate morphology	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	LMNB2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003794 delayed somite formation	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	TMED2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001333 absent optic nerve	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	TFAM
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004841 abnormal small intestine crypts of Lieberkuhn morphology	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009243 hairpin sperm flagellum	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011178 increased erythroblast number	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	MCM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013968 multiple persisting craniopharyngeal ducts	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000704 abnormal thymus development	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	RPL22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000813 abnormal hippocampus layer morphology	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	LMNB2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001236 abnormal epidermis stratum spinosum morphology	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001158 abnormal prostate gland morphology	1/15	0.21316629890593794	1.0	0	0	4.206098843322819	6.501294098250628	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011090 perinatal lethality, incomplete penetrance	6/256	0.22174569570105787	1.0	0	0	1.4787066246056784	2.227263508340278	YWHAE;HELLS;KHDRBS1;MCM3;RPL38;RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008762 embryonic lethality	2/56	0.22257834890853231	1.0	0	0	2.253267237494367	3.3854801925034845	MCM5;ILF2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004499 increased incidence of tumors by chemical induction	3/103	0.2240513292060016	1.0	0	0	1.8376159995099688	2.7488532145474265	HINT1;MSH2;SF1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003245 abnormal GABAergic neuron morphology	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002951 small thyroid gland	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002276 abnormal lung interstitium morphology	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	HAT1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005537 abnormal cerebral aqueduct morphology	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	UCHL5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000963 fused dorsal root ganglion	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013967 abnormal infrahyoid muscle connection	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013969 reduced sympathetic cervical ganglion size	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013859 abnormal vitelline vein connection	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005558 decreased creatinine clearance	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009758 impaired behavioral response to cocaine	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	PSMC5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003992 increased mortality induced by ionizing radiation	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000705 athymia	1/16	0.2256469557111145	1.0	0	0	3.943217665615142	5.8705979652933165	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003231 abnormal placenta vasculature	2/57	0.2284281151278476	1.0	0	0	2.213736233327799	3.268656179688163	HSP90AB1;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002189 abnormal myocardial trabeculae morphology	2/57	0.2284281151278476	1.0	0	0	2.213736233327799	3.268656179688163	YWHAE;BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004609 vertebral fusion	2/57	0.2284281151278476	1.0	0	0	2.213736233327799	3.268656179688163	CBX5;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003997 tonic-clonic seizures	2/58	0.23428829445817306	1.0	0	0	2.1755683672359405	3.1571911113861018	VCP;KDM1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001726 abnormal allantois morphology	2/58	0.23428829445817306	1.0	0	0	2.1755683672359405	3.1571911113861018	HDAC1;TMED2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011339 abnormal glomerular mesangium morphology	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004666 absent stapedial artery	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010865 prenatal growth retardation	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000441 increased cranium width	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011639 decreased mitochondrial DNA content	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	TFAM
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011024 abnormal branching involved in lung morphogenesis	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	OLA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011954 shortened PQ interval	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	UCK2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003456 absent tail	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000248 macrocytosis	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	LIG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013834 thin hypoglossal nerve	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008907 decreased total fat pad weight	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	EIF3M
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002606 increased basophil cell number	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	GCSH
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003216 absence seizures	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	KDM1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008714 increased lung carcinoma incidence	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009414 skeletal muscle fiber necrosis	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005573 increased pulmonary respiratory rate	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003123 paternal imprinting	1/17	0.2379302604460247	1.0	0	0	3.71126368528484	5.3285495327015004	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006410 abnormal common myeloid progenitor cell morphology	2/59	0.2401570937617512	1.0	0	0	2.138694327113297	3.050766213823958	NPM1;HMGB3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001575 cyanosis	5/210	0.24095442184133894	1.0	0	0	1.5021781583295781	2.1378210670984017	YWHAE;OLA1;USP1;YBX1;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010053 decreased grip strength	8/373	0.24139035206273216	1.0	0	0	1.3531685286829442	1.9233124722795067	VCP;UBE2I;PARP1;KDM1A;COX4I1;LSM1;SARS;TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000819 abnormal olfactory bulb morphology	2/60	0.2460327738737915	1.0	0	0	2.1030494216614093	2.949086277170319	RPL38;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002989 small kidney	3/109	0.2492951542348167	1.0	0	0	1.7364628252250167	2.412151291281038	HELLS;KDM1A;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004042 decreased susceptibility to kidney reperfusion injury	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006414 decreased T cell apoptosis	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	CCDC86
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011143 thick lung-associated mesenchyme	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	HAT1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005032 abnormal ectoplacental cone morphology	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	PTBP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010082 sternebra fusion	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011204 abnormal visceral yolk sac blood island morphology	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011453 abnormal glomerular capillary endothelium morphology	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002861 abnormal tail bud morphology	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	TMED2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010279 increased gastrointestinal tumor incidence	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0014018 embryo tumor	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013835 absent hypoglossal nerve	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008923 thoracoschisis	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004154 renal tubular necrosis	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010903 abnormal pulmonary alveolus wall morphology	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005477 increased circulating thyroxine level	1/18	0.2500193240039598	1.0	0	0	3.505082369435682	4.858805005577408	RAB5C
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006379 abnormal spermatocyte morphology	2/61	0.2519136482013628	1.0	0	0	2.068573201634173	2.8518775736912363	HSPA4;USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008734 decreased susceptibility to endotoxin shock	2/61	0.2519136482013628	1.0	0	0	2.068573201634173	2.8518775736912363	PARP1;GCA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001953 respiratory failure	4/161	0.2523714137233817	1.0	0	0	1.5674902521699945	2.158204302855613	HELLS;HAT1;YBX1;LMNB2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001680 abnormal mesoderm development	2/62	0.2577980815760506	1.0	0	0	2.0352091177368474	2.7588859876363094	DRAP1;DAD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005264 glomerulosclerosis	2/62	0.2577980815760506	1.0	0	0	2.0352091177368474	2.7588859876363094	DKC1;ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000826 abnormal third ventricle morphology	1/19	0.26191720835230675	1.0	0	0	3.320604349991698	4.448702718958836	UCHL5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002404 increased intestinal adenoma incidence	1/19	0.26191720835230675	1.0	0	0	3.320604349991698	4.448702718958836	POLD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004322 abnormal sternebra morphology	1/19	0.26191720835230675	1.0	0	0	3.320604349991698	4.448702718958836	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003157 impaired muscle relaxation	1/19	0.26191720835230675	1.0	0	0	3.320604349991698	4.448702718958836	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010308 decreased tumor latency	1/19	0.26191720835230675	1.0	0	0	3.320604349991698	4.448702718958836	MCM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008642 decreased circulating interleukin-1 beta level	1/19	0.26191720835230675	1.0	0	0	3.320604349991698	4.448702718958836	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005251 blepharitis	1/19	0.26191720835230675	1.0	0	0	3.320604349991698	4.448702718958836	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003324 increased liver adenoma incidence	1/19	0.26191720835230675	1.0	0	0	3.320604349991698	4.448702718958836	MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011095 embryonic lethality between implantation and placentation, complete penetrance	2/63	0.263684489016863	1.0	0	0	2.002904211106104	2.6698753350727533	GPX4;PCBP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011110 preweaning lethality, incomplete penetrance	13/669	0.2650795156908036	1.0	0	0	1.2259929363945432	1.627782009432908	IVNS1ABP;HSP90AA1;RRM1;CBX5;DDX27;PARP1;HP1BP3;LSM1;NUCKS1;HNRNPAB;SND1;G3BP1;TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011965 decreased total retina thickness	2/64	0.2695713346232164	1.0	0	0	1.971608832807571	2.5846258501153234	PARP1;LSM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009703 decreased birth body size	4/166	0.2697728742670591	1.0	0	0	1.5202766903576452	1.9918283309866245	HAT1;OLA1;BAZ1B;RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011099 lethality throughout fetal growth and development, complete penetrance	5/220	0.2707636646465357	1.0	0	0	1.4338973329509608	1.873399662698535	NPM1;LIG1;GLRX3;TCEA1;YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003186 abnormal redox activity	1/20	0.2736269274435734	1.0	0	0	3.1545741324921135	4.088295517532074	YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002018 increased malignant tumor incidence	1/20	0.2736269274435734	1.0	0	0	3.1545741324921135	4.088295517532074	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000087 absent mandible	1/20	0.2736269274435734	1.0	0	0	3.1545741324921135	4.088295517532074	HAT1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001694 absent egg cylinders	1/20	0.2736269274435734	1.0	0	0	3.1545741324921135	4.088295517532074	KDM1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005666 abnormal adipose tissue physiology	1/20	0.2736269274435734	1.0	0	0	3.1545741324921135	4.088295517532074	KHDRBS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008111 abnormal granulocyte differentiation	1/20	0.2736269274435734	1.0	0	0	3.1545741324921135	4.088295517532074	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001661 extended life span	1/20	0.2736269274435734	1.0	0	0	3.1545741324921135	4.088295517532074	UQCRFS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000088 short mandible	2/65	0.2754571303880224	1.0	0	0	1.941276389225916	2.5029328203332755	POLE4;BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002642 anisocytosis	2/65	0.2754571303880224	1.0	0	0	1.941276389225916	2.5029328203332755	NPM1;LIG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005090 increased double-negative T cell number	2/65	0.2754571303880224	1.0	0	0	1.941276389225916	2.5029328203332755	POLE4;HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001156 abnormal spermatogenesis	5/223	0.2798617135252274	1.0	0	0	1.4146072343013962	1.8014452732016268	RANBP1;CBX3;HSPA4;BSG;SNRPE
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001683 absent mesoderm	2/66	0.2813404349988138	1.0	0	0	1.911863110601281	2.42460535414608	RAD51;WLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003403 absent placental labyrinth	1/21	0.2851514477875881	1.0	0	0	3.0043563166591563	3.769670554629064	TMED2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003073 abnormal metacarpal bone morphology	1/21	0.2851514477875881	1.0	0	0	3.0043563166591563	3.769670554629064	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000350 abnormal cell proliferation	1/21	0.2851514477875881	1.0	0	0	3.0043563166591563	3.769670554629064	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011630 increased mitochondria size	1/21	0.2851514477875881	1.0	0	0	3.0043563166591563	3.769670554629064	TFAM
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010579 increased heart left ventricle size	1/21	0.2851514477875881	1.0	0	0	3.0043563166591563	3.769670554629064	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001704 abnormal dorsal-ventral axis patterning	1/21	0.2851514477875881	1.0	0	0	3.0043563166591563	3.769670554629064	G3BP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002021 increased incidence of induced tumors	1/21	0.2851514477875881	1.0	0	0	3.0043563166591563	3.769670554629064	MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008235 increased susceptibility to neuronal excitotoxicity	1/21	0.2851514477875881	1.0	0	0	3.0043563166591563	3.769670554629064	HNRNPAB
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001915 intracranial hemorrhage	2/67	0.28721985289189306	1.0	0	0	1.8833278402937992	2.3494652639559033	GLRX3;G3BP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001302 eyelids open at birth	2/67	0.28721985289189306	1.0	0	0	1.8833278402937992	2.3494652639559033	HMGB1;RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004046 abnormal mitosis	2/67	0.28721985289189306	1.0	0	0	1.8833278402937992	2.3494652639559033	HAT1;MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001672 abnormal embryo development	4/172	0.2909200761440382	1.0	0	0	1.4672437825544715	1.8116157317299024	POLE4;TMED2;RPL22L1;KIF22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000757 herniated abdominal wall	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004275 abnormal postnatal subventricular zone morphology	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010299 increased mammary gland tumor incidence	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010144 abnormal tumor vascularization	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	IDH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004617 sacral vertebral transformation	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001890 anencephaly	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010769 abnormal survival	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	UQCRFS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008481 increased spleen germinal center number	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013986 abnormal vitelline vein topology	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010182 decreased susceptibility to weight gain	1/22	0.2964936893879897	1.0	0	0	2.8677946659019216	3.4864621292052207	PCNA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000747 muscle weakness	2/69	0.2989616680985316	1.0	0	0	1.82873862753166	2.2080920114281093	VCP;MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009674 decreased birth weight	3/121	0.30083396125648537	1.0	0	0	1.5642516359465026	1.8789740441111868	HELLS;RPS19;HP1BP3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000928 incomplete rostral neuropore closure	2/70	0.3048214929240831	1.0	0	0	1.8026137899954933	2.141557355228316	RPL38;YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002398 abnormal bone marrow cell morphology/development	2/70	0.3048214929240831	1.0	0	0	1.8026137899954933	2.141557355228316	NPM1;DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0020476 abnormal circardian behavior entrainment	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	KDM1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002824 abnormal chorioallantoic fusion	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	DAD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002724 enhanced wound healing	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010506 prolonged RR interval	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	GCSH
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004160 retroesophageal right subclavian artery	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011405 tubulointerstitial nephritis	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002607 decreased basophil cell number	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002781 increased circulating testosterone level	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0014021 heterochrony	1/23	0.3076565262162307	1.0	0	0	2.74310794129749	3.23349689453046	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002599 increased mean platelet volume	2/71	0.31067228409718706	1.0	0	0	1.7772248633758387	2.077605493882316	NHP2;TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008261 arrest of male meiosis	3/124	0.3138337994842699	1.0	0	0	1.5264068383026357	1.7689402679484378	HSP90AA1;HSPA4;BSG
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005567 decreased circulating total protein level	2/72	0.3165128586812151	1.0	0	0	1.752541184717841	2.016108325409105	PES1;BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008280 abnormal male germ cell apoptosis	3/125	0.31817077397039634	1.0	0	0	1.5141955835962146	1.734006837023358	RANBP1;HSP90AA1;HSPA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001728 failure of embryo implantation	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	PSMC4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004860 dilated kidney collecting duct	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003050 abnormal sacral vertebrae morphology	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009647 decreased fertilization frequency	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	GPX4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000282 abnormal interatrial septum morphology	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003667 increased hemangiosarcoma incidence	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001963 abnormal hearing physiology	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0012764 increased alpha-beta T cell number	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	NDUFB8
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001545 abnormal hematopoietic system physiology	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011106 embryonic lethality between implantation and somite formation, incomplete penetrance	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	DAD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005399 increased susceptibility to fungal infection	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	PSME3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005232 abnormal mesenteric lymph node morphology	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010819 primary atelectasis	1/24	0.3186427871501954	1.0	0	0	2.6288117770767614	3.0065315276756337	HAT1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011101 prenatal lethality, incomplete penetrance	7/351	0.3227423912887853	1.0	0	0	1.2582346967205011	1.4229386555096295	FBL;PARP1;HDAC1;HAT1;MCM3;RPL38;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002230 abnormal primitive streak formation	1/25	0.3294552566033664	1.0	0	0	2.5236593059936907	2.802056090992216	DRAP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001916 intracerebral hemorrhage	1/25	0.3294552566033664	1.0	0	0	2.5236593059936907	2.802056090992216	YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002237 abnormal nasal cavity morphology	1/25	0.3294552566033664	1.0	0	0	2.5236593059936907	2.802056090992216	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000823 abnormal lateral ventricle morphology	1/25	0.3294552566033664	1.0	0	0	2.5236593059936907	2.802056090992216	UCHL5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003072 abnormal metatarsal bone morphology	1/25	0.3294552566033664	1.0	0	0	2.5236593059936907	2.802056090992216	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006387 abnormal T cell number	1/25	0.3294552566033664	1.0	0	0	2.5236593059936907	2.802056090992216	RPL22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004084 abnormal cardiac muscle relaxation	1/25	0.3294552566033664	1.0	0	0	2.5236593059936907	2.802056090992216	GLRX3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000603 pale liver	2/75	0.33396204014430303	1.0	0	0	1.6824395373291274	1.845178455902268	LIG1;TCEA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001177 atelectasis	2/75	0.33396204014430303	1.0	0	0	1.6824395373291274	1.845178455902268	HELLS;HMGB1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004227 increased cellular sensitivity to ionizing radiation	1/26	0.3400966752015053	1.0	0	0	2.426595486532395	2.6171447778708963	SMC1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000131 abnormal long bone epiphysis morphology	1/26	0.3400966752015053	1.0	0	0	2.426595486532395	2.6171447778708963	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0012113 decreased inner cell mass proliferation	1/26	0.3400966752015053	1.0	0	0	2.426595486532395	2.6171447778708963	RUVBL1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001852 conjunctivitis	1/26	0.3400966752015053	1.0	0	0	2.426595486532395	2.6171447778708963	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008108 abnormal small intestinal villus morphology	1/26	0.3400966752015053	1.0	0	0	2.426595486532395	2.6171447778708963	MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003355 decreased ovulation rate	1/26	0.3400966752015053	1.0	0	0	2.426595486532395	2.6171447778708963	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008284 abnormal hippocampus pyramidal cell layer	1/26	0.3400966752015053	1.0	0	0	2.426595486532395	2.6171447778708963	YWHAE
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002152 abnormal brain morphology	4/187	0.3445646000242675	1.0	0	0	1.349550431012669	1.4379104747314746	YWHAE;VCP;NPM1;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000333 decreased bone marrow cell number	2/77	0.3455237924242749	1.0	0	0	1.6387398090868124	1.741478592976884	DKC1;USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001845 abnormal inflammatory response	2/77	0.3455237924242749	1.0	0	0	1.6387398090868124	1.741478592976884	PARP1;MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004057 thin myocardium compact layer	1/27	0.35056974048286826	1.0	0	0	2.336721579623788	2.4493413203101504	YWHAE
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000049 abnormal middle ear morphology	1/27	0.35056974048286826	1.0	0	0	2.336721579623788	2.4493413203101504	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005634 decreased circulating sodium level	1/27	0.35056974048286826	1.0	0	0	2.336721579623788	2.4493413203101504	UQCRB
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003718 maternal effect	2/79	0.3570195111243976	1.0	0	0	1.5972527253124629	1.6451141567486365	G3BP1;EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002161 abnormal fertility/fecundity	2/79	0.3570195111243976	1.0	0	0	1.5972527253124629	1.6451141567486365	DKC1;ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005505 thrombocytosis	2/79	0.3570195111243976	1.0	0	0	1.5972527253124629	1.6451141567486365	POLE4;NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002233 abnormal nose morphology	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	HAT1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010763 abnormal hematopoietic stem cell physiology	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004808 abnormal hematopoietic stem cell morphology	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	TCEA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009790 decreased susceptibility to viral infection induced morbidity/mortality	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	LSM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004101 abnormal brain interneuron morphology	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009237 kinked sperm flagellum	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	GPX4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009832 abnormal sperm mitochondrial sheath morphology	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	GPX4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013840 absent segment of posterior cerebral artery	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011320 abnormal glomerular capillary morphology	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006050 pulmonary fibrosis	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	TOMM5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002887 decreased susceptibility to pharmacologically induced seizures	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	KDM1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008019 increased liver tumor incidence	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011104 embryonic lethality before implantation, incomplete penetrance	1/28	0.3608771076047978	1.0	0	0	2.253267237494367	2.2965700783087053	KIF22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003232 abnormal forebrain development	2/81	0.3684419237745489	1.0	0	0	1.5578143864158585	1.555434328730751	NPM1;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000322 increased granulocyte number	2/81	0.3684419237745489	1.0	0	0	1.5578143864158585	1.555434328730751	POLE4;NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000060 delayed bone ossification	2/81	0.3684419237745489	1.0	0	0	1.5578143864158585	1.555434328730751	HELLS;USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006378 abnormal spermatogonia morphology	1/29	0.3710213899619185	1.0	0	0	2.1755683672359405	2.157066383450023	USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010413 complete atrioventricular septal defect	1/29	0.3710213899619185	1.0	0	0	2.1755683672359405	2.157066383450023	SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009640 abnormal renal tubule epithelium morphology	1/29	0.3710213899619185	1.0	0	0	2.1755683672359405	2.157066383450023	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006413 increased T cell apoptosis	1/29	0.3710213899619185	1.0	0	0	2.1755683672359405	2.157066383450023	RPL22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000102 abnormal nasal bone morphology	1/29	0.3710213899619185	1.0	0	0	2.1755683672359405	2.157066383450023	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011346 renal tubule atrophy	1/29	0.3710213899619185	1.0	0	0	2.1755683672359405	2.157066383450023	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003827 abnormal Wolffian duct morphology	1/29	0.3710213899619185	1.0	0	0	2.1755683672359405	2.157066383450023	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004992 increased bone resorption	1/29	0.3710213899619185	1.0	0	0	2.1755683672359405	2.157066383450023	USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003868 abnormal feces composition	1/29	0.3710213899619185	1.0	0	0	2.1755683672359405	2.157066383450023	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000493 rectal prolapse	1/29	0.3710213899619185	1.0	0	0	2.1755683672359405	2.157066383450023	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001153 small seminiferous tubules	2/83	0.3797842773884226	1.0	0	0	1.5202766903576452	1.4718587336739717	HSPA4;RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008259 abnormal optic disk morphology	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	RCC2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008911 induced hyperactivity	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004229 abnormal embryonic erythropoiesis	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011635 abnormal mitochondrial crista morphology	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010090 increased circulating creatine kinase level	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	PES1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002396 abnormal hematopoietic system morphology/development	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010169 decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004268 abnormal optic stalk morphology	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011400 lethality, complete penetrance	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	BCAS2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013876 absent ductus venosus valve	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013877 abnormal ductus venosus valve morphology	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002768 small adrenal glands	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	DDOST
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000334 decreased granulocyte number	1/30	0.3810051598406185	1.0	0	0	2.1030494216614093	2.0293214743604158	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009142 decreased prepulse inhibition	4/198	0.3840988460184794	1.0	0	0	1.2745754070675208	1.219584294697908	ATP5B;MAT2A;FAM53B;HNRNPAB
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004852 decreased testis weight	5/258	0.3888296480475625	1.0	0	0	1.2227031521287262	1.1549824591455429	HSP90AA1;CCND2;HSPA4;SNRPE;EIF2S2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003691 abnormal microglial cell physiology	1/31	0.3908309491361509	1.0	0	0	2.0352091177368474	1.9120386031132952	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002177 abnormal outer ear morphology	1/31	0.3908309491361509	1.0	0	0	2.0352091177368474	1.9120386031132952	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009293 decreased inguinal fat pad weight	1/31	0.3908309491361509	1.0	0	0	2.0352091177368474	1.9120386031132952	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004357 long tibia	1/31	0.3908309491361509	1.0	0	0	2.0352091177368474	1.9120386031132952	IDH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008146 asymmetric sternocostal joints	1/31	0.3908309491361509	1.0	0	0	2.0352091177368474	1.9120386031132952	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008022 dilated heart ventricle	1/31	0.3908309491361509	1.0	0	0	2.0352091177368474	1.9120386031132952	YWHAE
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001272 increased metastatic potential	1/31	0.3908309491361509	1.0	0	0	2.0352091177368474	1.9120386031132952	MCM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002643 poikilocytosis	1/31	0.3908309491361509	1.0	0	0	2.0352091177368474	1.9120386031132952	LIG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013836 abnormal hypoglossal nerve topology	1/31	0.3908309491361509	1.0	0	0	2.0352091177368474	1.9120386031132952	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001928 abnormal ovulation	1/31	0.3908309491361509	1.0	0	0	2.0352091177368474	1.9120386031132952	CCND2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002608 increased hematocrit	2/85	0.3910403136141792	1.0	0	0	1.484505474113936	1.3938684289315706	ARF2;HMGB3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006009 abnormal neuronal migration	2/85	0.3910403136141792	1.0	0	0	1.484505474113936	1.3938684289315706	YWHAE;LMNB2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000592 short tail	3/143	0.3958761722421989	1.0	0	0	1.3235975381085792	1.2265167055464563	RPL31;G3BP1;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011402 renal cast	1/32	0.4005012498930377	1.0	0	0	1.971608832807571	1.804097775329334	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009831 abnormal sperm midpiece morphology	1/32	0.4005012498930377	1.0	0	0	1.971608832807571	1.804097775329334	GPX4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000748 progressive muscle weakness	1/32	0.4005012498930377	1.0	0	0	1.971608832807571	1.804097775329334	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010168 increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	1/32	0.4005012498930377	1.0	0	0	1.971608832807571	1.804097775329334	NDUFB8
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003396 abnormal embryonic hematopoiesis	1/32	0.4005012498930377	1.0	0	0	1.971608832807571	1.804097775329334	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005326 abnormal podocyte morphology	1/32	0.4005012498930377	1.0	0	0	1.971608832807571	1.804097775329334	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003786 premature aging	1/32	0.4005012498930377	1.0	0	0	1.971608832807571	1.804097775329334	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001825 arrested T cell differentiation	1/32	0.4005012498930377	1.0	0	0	1.971608832807571	1.804097775329334	RPL22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008814 decreased nerve conduction velocity	1/32	0.4005012498930377	1.0	0	0	1.971608832807571	1.804097775329334	CANX
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005225 abnormal vertebrae development	1/32	0.4005012498930377	1.0	0	0	1.971608832807571	1.804097775329334	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008540 abnormal cerebral hemisphere morphology	1/32	0.4005012498930377	1.0	0	0	1.971608832807571	1.804097775329334	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000790 abnormal stratification in cerebral cortex	1/32	0.4005012498930377	1.0	0	0	1.971608832807571	1.804097775329334	LMNB2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001711 abnormal placenta morphology	2/87	0.4022042441906066	1.0	0	0	1.450378911490627	1.3209982222142282	COX7C;RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001925 male infertility	13/747	0.4051831137882764	1.0	0	0	1.0979776097027438	0.9919307392515708	RANBP1;KHDRBS1;HSP90AA1;GPX4;CBX3;HSPA4;BZW1;RAD23B;ARHGDIA;BSG;USP1;EIF4H;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002764 short tibia	4/204	0.4055663776528032	1.0	0	0	1.2370878950949464	1.1164356101620547	GCSH;POLE4;HELLS;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002875 decreased erythrocyte cell number	4/204	0.4055663776528032	1.0	0	0	1.2370878950949464	1.1164356101620547	HINT1;RPL32;RPS19;FAM53B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002705 dilated renal tubules	2/88	0.4077499838525857	1.0	0	0	1.4338973329509608	1.28635084181571	HELLS;ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000460 mandible hypoplasia	1/33	0.410018514990012	1.0	0	0	1.911863110601281	1.7045272187958591	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000575 increased foot pad pigmentation	1/33	0.410018514990012	1.0	0	0	1.911863110601281	1.7045272187958591	RPS19
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002286 cryptorchism	1/33	0.410018514990012	1.0	0	0	1.911863110601281	1.7045272187958591	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004148 increased compact bone thickness	1/33	0.410018514990012	1.0	0	0	1.911863110601281	1.7045272187958591	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001015 small superior cervical ganglion	1/33	0.410018514990012	1.0	0	0	1.911863110601281	1.7045272187958591	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001850 increased susceptibility to otitis media	1/33	0.410018514990012	1.0	0	0	1.911863110601281	1.7045272187958591	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008479 decreased spleen white pulp amount	1/33	0.410018514990012	1.0	0	0	1.911863110601281	1.7045272187958591	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002417 abnormal megakaryocyte morphology	1/33	0.410018514990012	1.0	0	0	1.911863110601281	1.7045272187958591	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002998 abnormal bone remodeling	1/34	0.4193851587034612	1.0	0	0	1.85563184264242	1.6124801412388206	KHDRBS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000930 wavy neural tube	1/34	0.4193851587034612	1.0	0	0	1.85563184264242	1.6124801412388206	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004890 decreased energy expenditure	1/34	0.4193851587034612	1.0	0	0	1.85563184264242	1.6124801412388206	NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010373 myeloid hyperplasia	1/34	0.4193851587034612	1.0	0	0	1.85563184264242	1.6124801412388206	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001157 small seminal vesicle	1/34	0.4193851587034612	1.0	0	0	1.85563184264242	1.6124801412388206	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004956 decreased thymus weight	1/34	0.4193851587034612	1.0	0	0	1.85563184264242	1.6124801412388206	DAD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003826 abnormal Mullerian duct morphology	1/34	0.4193851587034612	1.0	0	0	1.85563184264242	1.6124801412388206	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001413 abnormal response to new environment	1/34	0.4193851587034612	1.0	0	0	1.85563184264242	1.6124801412388206	MYG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001130 abnormal ovarian folliculogenesis	1/34	0.4193851587034612	1.0	0	0	1.85563184264242	1.6124801412388206	CCND2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003632 abnormal nervous system morphology	2/91	0.4242348479940318	1.0	0	0	1.386625992304226	1.1889875415959583	CANX;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004893 decreased adiponectin level	1/35	0.4286035573292328	1.0	0	0	1.8026137899954933	1.5272156757017634	NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010956 abnormal mitochondrial ATP synthesis coupled electron transport	1/35	0.4286035573292328	1.0	0	0	1.8026137899954933	1.5272156757017634	TFAM
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001199 thin skin	1/35	0.4286035573292328	1.0	0	0	1.8026137899954933	1.5272156757017634	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005089 decreased double-negative T cell number	1/35	0.4286035573292328	1.0	0	0	1.8026137899954933	1.5272156757017634	RPL22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002843 decreased systemic arterial blood pressure	1/35	0.4286035573292328	1.0	0	0	1.8026137899954933	1.5272156757017634	ADH5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005568 increased circulating total protein level	1/35	0.4286035573292328	1.0	0	0	1.8026137899954933	1.5272156757017634	RAB5C
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005277 abnormal brainstem morphology	1/35	0.4286035573292328	1.0	0	0	1.8026137899954933	1.5272156757017634	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002084 abnormal developmental patterning	2/92	0.4296770962089663	1.0	0	0	1.371553970648745	1.1585808413652523	RBBP7;WLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001176 abnormal lung development	2/93	0.4350920914994303	1.0	0	0	1.3568060784912317	1.1291307156518668	HAT1;OLA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008813 decreased common myeloid progenitor cell number	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013241 embryo tissue necrosis	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	HSP90AB1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000372 irregular coat pigmentation	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009767 decreased sensitivity to xenobiotic induced morbidity/mortality	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	KDM1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003020 decreased circulating chloride level	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	UQCRB
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001693 failure of primitive streak formation	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	WLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001458 abnormal object recognition memory	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003222 increased cardiomyocyte apoptosis	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	IVNS1ABP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004620 cervical vertebral fusion	1/36	0.43767604978190794	1.0	0	0	1.752541184717841	1.4480831661828433	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013278 decreased fasting circulating glucose level	2/94	0.4404793295239362	1.0	0	0	1.3423719712732398	1.100599717749793	RCC2;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000438 abnormal cranium morphology	3/155	0.4464343561570249	1.0	0	0	1.2211254706421086	0.9847923982812627	KARS;HAT1;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004252 abnormal direction of heart looping	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	TMED2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003686 abnormal eye muscle morphology	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001179 thick pulmonary interalveolar septum	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	HAT1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004485 increased response of heart to induced stress	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	GLRX3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002766 situs inversus	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002455 abnormal dendritic cell antigen presentation	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	HSP90AA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002058 neonatal lethality	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	OLA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000889 abnormal cerebellar molecular layer	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	CCND2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000857 abnormal cerebellar foliation	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	CCND2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005605 increased bone mass	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	KHDRBS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003204 decreased neuron apoptosis	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009403 increased variability of skeletal muscle fiber size	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005217 abnormal pancreatic beta cell morphology	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	RPS6
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001951 abnormal breathing pattern	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002067 abnormal sensory capabilities/reflexes/nociception	1/37	0.4466049384207956	1.0	0	0	1.7051752067524943	1.3745091343180766	ATP5B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002591 decreased mean corpuscular volume	3/157	0.4547046237297652	1.0	0	0	1.2055697321625911	0.9501182456405768	UQCRQ;RCC2;HMGB3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002216 abnormal seminiferous tubule morphology	3/157	0.4547046237297652	1.0	0	0	1.2055697321625911	0.9501182456405768	CBX3;HSPA4;ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004355 short radius	1/38	0.4553924889390075	1.0	0	0	1.660302174995849	1.3059864167611546	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000938 motor neuron degeneration	1/38	0.4553924889390075	1.0	0	0	1.660302174995849	1.3059864167611546	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003864 abnormal midbrain development	1/38	0.4553924889390075	1.0	0	0	1.660302174995849	1.3059864167611546	COX4I1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000443 abnormal snout morphology	1/38	0.4553924889390075	1.0	0	0	1.660302174995849	1.3059864167611546	HSP90AA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0020470 shortened circadian behavior period	1/38	0.4553924889390075	1.0	0	0	1.660302174995849	1.3059864167611546	NONO
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005641 increased mean corpuscular hemoglobin concentration	1/38	0.4553924889390075	1.0	0	0	1.660302174995849	1.3059864167611546	HINT1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002115 abnormal limb bone morphology	1/38	0.4553924889390075	1.0	0	0	1.660302174995849	1.3059864167611546	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004686 decreased length of long bones	2/97	0.456469792257573	1.0	0	0	1.300855312367882	1.020173343690182	RPL38;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001700 abnormal embryo turning	2/98	0.4617414020426216	1.0	0	0	1.2875812785682097	0.994978794115064	TMED2;RBBP7
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010052 increased grip strength	3/159	0.4629232852936195	1.0	0	0	1.1904053330158921	0.9168429606983312	HSP90AA1;CBX5;LSM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002825 abnormal notochord morphology	1/39	0.4640409318233614	1.0	0	0	1.61773032435493	1.242065057850123	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005033 abnormal trophoblast giant cell morphology	1/39	0.4640409318233614	1.0	0	0	1.61773032435493	1.242065057850123	SSB
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000781 decreased corpus callosum size	1/39	0.4640409318233614	1.0	0	0	1.61773032435493	1.242065057850123	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008525 decreased cranium height	1/39	0.4640409318233614	1.0	0	0	1.61773032435493	1.242065057850123	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004471 short nasal bone	1/39	0.4640409318233614	1.0	0	0	1.61773032435493	1.242065057850123	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001239 abnormal epidermis stratum granulosum morphology	1/39	0.4640409318233614	1.0	0	0	1.61773032435493	1.242065057850123	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001533 abnormal skeleton physiology	1/39	0.4640409318233614	1.0	0	0	1.61773032435493	1.242065057850123	KHDRBS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010418 perimembraneous ventricular septal defect	2/99	0.4669830613831871	1.0	0	0	1.2745754070675208	0.970541112193394	H13;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002574 increased vertical activity	2/99	0.4669830613831871	1.0	0	0	1.2745754070675208	0.970541112193394	TARDBP;RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000788 abnormal cerebral cortex morphology	3/161	0.4710879856920933	1.0	0	0	1.175617689127496	0.8848996566469286	YWHAE;LMNB2;UCHL5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001262 decreased body weight	24/1471	0.4721076232357382	1.0	0	0	1.0293647747085075	0.7725879859146929	HELLS;RANBP1;KHDRBS1;VCP;PCNA;PARP1;LIG1;ATP5A1;ATPIF1;HP1BP3;OLA1;BAZ1B;POLE4;HINT1;EIF3M;RPS19;DKC1;PCBP1;BSG;RUVBL1;USP1;EIF4H;RPL38;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000913 abnormal brain development	2/100	0.472194393604549	1.0	0	0	1.2618296529968456	0.9468322111378824	YBX1;UCHL5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005013 increased lymphocyte cell number	2/100	0.472194393604549	1.0	0	0	1.2618296529968456	0.9468322111378824	RPA1;TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000709 enlarged thymus	1/40	0.4725524621978995	1.0	0	0	1.5772870662460567	1.1823446484308693	POLD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003733 abnormal retinal inner nuclear layer morphology	1/40	0.4725524621978995	1.0	0	0	1.5772870662460567	1.1823446484308693	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000596 abnormal liver development	1/40	0.4725524621978995	1.0	0	0	1.5772870662460567	1.1823446484308693	LIG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000716 abnormal immune system cell morphology	1/40	0.4725524621978995	1.0	0	0	1.5772870662460567	1.1823446484308693	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004016 decreased bone mass	1/40	0.4725524621978995	1.0	0	0	1.5772870662460567	1.1823446484308693	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004269 abnormal optic cup morphology	1/40	0.4725524621978995	1.0	0	0	1.5772870662460567	1.1823446484308693	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004910 decreased seminal vesicle weight	1/41	0.4809292408849708	1.0	0	0	1.538816649996153	1.126467843417903	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004736 abnormal distortion product otoacoustic emission	1/41	0.4809292408849708	1.0	0	0	1.538816649996153	1.126467843417903	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000886 abnormal cerebellar granule layer morphology	1/41	0.4809292408849708	1.0	0	0	1.538816649996153	1.126467843417903	CCND2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008415 abnormal neurite morphology	1/41	0.4809292408849708	1.0	0	0	1.538816649996153	1.126467843417903	HNRNPAB
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002066 abnormal motor capabilities/coordination/movement	3/164	0.4832289934703842	1.0	0	0	1.1541124874971147	0.8393451924889921	HSPA4;TARDBP;RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000189 hypoglycemia	2/103	0.4876429477130673	1.0	0	0	1.225077333006646	0.8798160000594317	HELLS;HMGB1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003178 left pulmonary isomerism	1/42	0.4891733944207034	1.0	0	0	1.5021781583295781	1.0741148603605042	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000480 increased rib number	1/42	0.4891733944207034	1.0	0	0	1.5021781583295781	1.0741148603605042	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000872 abnormal cerebellum external granule cell layer morphology	1/42	0.4891733944207034	1.0	0	0	1.5021781583295781	1.0741148603605042	CCND2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004616 lumbar vertebral transformation	1/42	0.4891733944207034	1.0	0	0	1.5021781583295781	1.0741148603605042	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008037 abnormal T cell morphology	1/42	0.4891733944207034	1.0	0	0	1.5021781583295781	1.0741148603605042	CCDC86
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005296 abnormal humerus morphology	1/42	0.4891733944207034	1.0	0	0	1.5021781583295781	1.0741148603605042	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008943 increased sensitivity to induced cell death	1/42	0.4891733944207034	1.0	0	0	1.5021781583295781	1.0741148603605042	IVNS1ABP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005164 abnormal response to injury	1/42	0.4891733944207034	1.0	0	0	1.5021781583295781	1.0741148603605042	KPNB1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003674 oxidative stress	2/104	0.4927295838649702	1.0	0	0	1.2132977432661975	0.8587657933231668	GPX4;DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006108 abnormal hindbrain development	1/43	0.4972870161437867	1.0	0	0	1.4672437825544715	1.0249987855647944	COX4I1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010876 decreased bone volume	1/43	0.4972870161437867	1.0	0	0	1.4672437825544715	1.0249987855647944	USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000628 abnormal mammary gland development	1/43	0.4972870161437867	1.0	0	0	1.4672437825544715	1.0249987855647944	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013848 subcutaneous edema	1/43	0.4972870161437867	1.0	0	0	1.4672437825544715	1.0249987855647944	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008948 decreased neuron number	1/43	0.4972870161437867	1.0	0	0	1.4672437825544715	1.0249987855647944	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000267 abnormal heart development	3/168	0.4992081961131963	1.0	0	0	1.1266336187471837	0.7827084763020675	TFAM;TMED2;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003109 short femur	2/106	0.5028067969917752	1.0	0	0	1.1904053330158921	0.8184623344756145	HELLS;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000186 decreased circulating HDL cholesterol level	3/169	0.5031641005452689	1.0	0	0	1.1199671476303363	0.7692370243886063	RPA1;NUCKS1;BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009395 increased nucleated erythrocyte cell number	1/44	0.5052721663453871	1.0	0	0	1.4338973329509608	0.9788615595445136	LIG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004110 transposition of great arteries	1/44	0.5052721663453871	1.0	0	0	1.4338973329509608	0.9788615595445136	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003606 kidney failure	1/44	0.5052721663453871	1.0	0	0	1.4338973329509608	0.9788615595445136	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000602 enlarged liver sinusoidal spaces	1/44	0.5052721663453871	1.0	0	0	1.4338973329509608	0.9788615595445136	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004251 failure of heart looping	1/44	0.5052721663453871	1.0	0	0	1.4338973329509608	0.9788615595445136	TMED2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010088 decreased circulating fructosamine level	1/44	0.5052721663453871	1.0	0	0	1.4338973329509608	0.9788615595445136	PES1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001145 abnormal male reproductive system morphology	1/44	0.5052721663453871	1.0	0	0	1.4338973329509608	0.9788615595445136	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011275 abnormal behavioral response to light	2/107	0.50779685434817	1.0	0	0	1.179280049529762	0.7991671976150275	EEF1B2;NPM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008873 increased physiological sensitivity to xenobiotic	2/107	0.50779685434817	1.0	0	0	1.179280049529762	0.7991671976150275	IVNS1ABP;ADH5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002270 abnormal pulmonary alveolus morphology	2/108	0.5127542261061547	1.0	0	0	1.168360789811894	0.7804166842193367	DKC1;G3BP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013971 blood in lymph vessels	1/45	0.5131308728841566	1.0	0	0	1.4020329477742728	0.935470527181914	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002754 dilated heart right ventricle	1/45	0.5131308728841566	1.0	0	0	1.4020329477742728	0.935470527181914	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000914 exencephaly	4/236	0.5164105151548107	1.0	0	0	1.0693471635566487	0.7066815567500259	RPL38;H13;YBX1;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004351 short humerus	1/46	0.520865131725754	1.0	0	0	1.371553970648745	0.8946154642571605	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005650 abnormal limb bud morphology	1/46	0.520865131725754	1.0	0	0	1.371553970648745	0.8946154642571605	COX7C
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009456 impaired cued conditioning behavior	1/46	0.520865131725754	1.0	0	0	1.371553970648745	0.8946154642571605	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011239 abnormal skin coloration	1/46	0.520865131725754	1.0	0	0	1.371553970648745	0.8946154642571605	COX7C
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004090 abnormal sarcomere morphology	1/46	0.520865131725754	1.0	0	0	1.371553970648745	0.8946154642571605	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004024 aneuploidy	1/46	0.520865131725754	1.0	0	0	1.371553970648745	0.8946154642571605	MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000609 abnormal liver physiology	2/110	0.5225700477490429	1.0	0	0	1.1471178663607686	0.7444751837696295	NONO;MCM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005553 increased circulating creatinine level	2/110	0.5225700477490429	1.0	0	0	1.1471178663607686	0.7444751837696295	ARHGDIA;LMNB2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002086 abnormal extraembryonic tissue morphology	2/111	0.5274281024369116	1.0	0	0	1.1367834711683291	0.7272489517369768	GPX4;DAD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000418 focal hair loss	1/47	0.5284769075012126	1.0	0	0	1.3423719712732398	0.8561060058290406	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001675 abnormal ectoderm development	1/47	0.5284769075012126	1.0	0	0	1.3423719712732398	0.8561060058290406	WLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000066 osteoporosis	1/47	0.5284769075012126	1.0	0	0	1.3423719712732398	0.8561060058290406	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011186 abnormal visceral endoderm morphology	1/47	0.5284769075012126	1.0	0	0	1.3423719712732398	0.8561060058290406	DAD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000565 oligodactyly	1/47	0.5284769075012126	1.0	0	0	1.3423719712732398	0.8561060058290406	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001802 arrested B cell differentiation	1/47	0.5284769075012126	1.0	0	0	1.3423719712732398	0.8561060058290406	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008260 abnormal autophagy	1/47	0.5284769075012126	1.0	0	0	1.3423719712732398	0.8561060058290406	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008554 decreased circulating tumor necrosis factor level	1/47	0.5284769075012126	1.0	0	0	1.3423719712732398	0.8561060058290406	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002095 abnormal skin pigmentation	1/48	0.535968133783962	1.0	0	0	1.3144058885383807	0.8197694158441934	RPS19
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000751 myopathy	1/48	0.535968133783962	1.0	0	0	1.3144058885383807	0.8197694158441934	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000849 abnormal cerebellum morphology	2/113	0.5370436195376718	1.0	0	0	1.1166634097317216	0.6942027967759361	CCND2;LMNB2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002108 abnormal muscle morphology	1/49	0.5433407139272783	1.0	0	0	1.2875812785682097	0.7854486448547775	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002032 increased sarcoma incidence	1/49	0.5433407139272783	1.0	0	0	1.2875812785682097	0.7854486448547775	POLD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001622 abnormal vasculogenesis	1/49	0.5433407139272783	1.0	0	0	1.2875812785682097	0.7854486448547775	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000269 abnormal heart looping	1/49	0.5433407139272783	1.0	0	0	1.2875812785682097	0.7854486448547775	TMED2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002007 increased cellular sensitivity to gamma-irradiation	1/49	0.5433407139272783	1.0	0	0	1.2875812785682097	0.7854486448547775	RAD51
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004007 abnormal lung vasculature morphology	1/49	0.5433407139272783	1.0	0	0	1.2875812785682097	0.7854486448547775	TOMM5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009766 increased sensitivity to xenobiotic induced morbidity/mortality	2/115	0.5465240001102099	1.0	0	0	1.0972431765189958	0.6629291524346873	IVNS1ABP;ADH5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006362 abnormal male germ cell morphology	1/50	0.5505965210056286	1.0	0	0	1.2618296529968456	0.753000637028314	USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004810 decreased hematopoietic stem cell number	1/50	0.5505965210056286	1.0	0	0	1.2618296529968456	0.753000637028314	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005330 cardiomyopathy	1/50	0.5505965210056286	1.0	0	0	1.2618296529968456	0.753000637028314	POLD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003871 abnormal myelin sheath morphology	1/50	0.5505965210056286	1.0	0	0	1.2618296529968456	0.753000637028314	CANX
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000120 malocclusion	1/50	0.5505965210056286	1.0	0	0	1.2618296529968456	0.753000637028314	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003047 abnormal thoracic vertebrae morphology	1/50	0.5505965210056286	1.0	0	0	1.2618296529968456	0.753000637028314	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005006 abnormal osteoblast physiology	1/50	0.5505965210056286	1.0	0	0	1.2618296529968456	0.753000637028314	KHDRBS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003419 delayed endochondral bone ossification	1/50	0.5505965210056286	1.0	0	0	1.2618296529968456	0.753000637028314	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009937 abnormal neuron differentiation	2/116	0.551213183334041	1.0	0	0	1.0877841836179702	0.6479208550572385	HNRNPAB;UCHL5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002968 increased circulating alkaline phosphatase level	4/248	0.5555158102708364	1.0	0	0	1.0176045588684235	0.5982071934199955	MCTS1;RAB5C;NAA10;DENR
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005017 decreased B cell number	4/248	0.5555158102708364	1.0	0	0	1.0176045588684235	0.5982071934199955	POLE4;HELLS;DKC1;RPL22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000240 extramedullary hematopoiesis	2/117	0.5558682106021031	1.0	0	0	1.0784868829032868	0.6333134289078622	NPM1;DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003111 abnormal cell nucleus morphology	1/51	0.5577373989907868	1.0	0	0	1.2370878950949464	0.7222948456740522	MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003918 decreased kidney weight	1/51	0.5577373989907868	1.0	0	0	1.2370878950949464	0.7222948456740522	EIF3M
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008008 early cellular replicative senescence	1/51	0.5577373989907868	1.0	0	0	1.2370878950949464	0.7222948456740522	YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001529 abnormal vocalization	1/51	0.5577373989907868	1.0	0	0	1.2370878950949464	0.7222948456740522	ADH5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004259 small placenta	1/51	0.5577373989907868	1.0	0	0	1.2370878950949464	0.7222948456740522	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005150 cachexia	2/118	0.5604889834488984	1.0	0	0	1.0693471635566487	0.6190939330875024	HELLS;HMGB1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005266 abnormal metabolism	1/52	0.5647651625200546	1.0	0	0	1.2132977432661975	0.6932119337491098	ADH5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004948 abnormal neuronal precursor proliferation	1/52	0.5647651625200546	1.0	0	0	1.2132977432661975	0.6932119337491098	LMNB2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003054 spina bifida	1/52	0.5647651625200546	1.0	0	0	1.2132977432661975	0.6932119337491098	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004509 abnormal pelvic girdle bone morphology	1/52	0.5647651625200546	1.0	0	0	1.2132977432661975	0.6932119337491098	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001322 abnormal iris morphology	1/52	0.5647651625200546	1.0	0	0	1.2132977432661975	0.6932119337491098	TMEM165
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005562 decreased mean corpuscular hemoglobin	2/119	0.5650754153182387	1.0	0	0	1.0603610529385257	0.6052499306033876	RAB5C;UQCRQ
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000284 double outlet right ventricle	3/186	0.567808503970182	1.0	0	0	1.0176045588684235	0.5759347288117653	H13;BAZ1B;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003644 thymus atrophy	1/53	0.571681597834106	1.0	0	0	1.1904053330158921	0.6656426280948146	TOMM5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004543 abnormal sperm physiology	1/53	0.571681597834106	1.0	0	0	1.1904053330158921	0.6656426280948146	GPX4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003048 abnormal cervical vertebrae morphology	1/53	0.571681597834106	1.0	0	0	1.1904053330158921	0.6656426280948146	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010948 abnormal double-strand DNA break repair	1/53	0.571681597834106	1.0	0	0	1.1904053330158921	0.6656426280948146	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005215 abnormal pancreatic islet morphology	1/53	0.571681597834106	1.0	0	0	1.1904053330158921	0.6656426280948146	RPS6
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003156 abnormal leukocyte migration	1/53	0.571681597834106	1.0	0	0	1.1904053330158921	0.6656426280948146	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001304 cataract	4/255	0.5775351854552664	1.0	0	0	0.9896703160759572	0.5433150603049749	MCTS1;UQCRB;HDAC1;BZW1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000558 abnormal tibia morphology	1/54	0.5784884629882517	1.0	0	0	1.168360789811894	0.6394867105076507	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002784 abnormal Sertoli cell morphology	1/54	0.5784884629882517	1.0	0	0	1.168360789811894	0.6394867105076507	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002410 decreased susceptibility to viral infection	1/54	0.5784884629882517	1.0	0	0	1.168360789811894	0.6394867105076507	LSM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003052 omphalocele	1/54	0.5784884629882517	1.0	0	0	1.168360789811894	0.6394867105076507	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005159 azoospermia	3/190	0.5822536864582181	1.0	0	0	0.9961813049975096	0.5387837013150468	RANBP1;HSP90AA1;BSG
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002145 abnormal T cell differentiation	2/123	0.5830763861418393	1.0	0	0	1.025877766664102	0.5533965055244543	POLE4;RPL22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000774 decreased brain size	2/123	0.5830763861418393	1.0	0	0	1.025877766664102	0.5533965055244543	EIF4H;LMNB2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005140 decreased cardiac muscle contractility	2/123	0.5830763861418393	1.0	0	0	1.025877766664102	0.5533965055244543	IVNS1ABP;GLRX3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003447 decreased tumor growth/size	1/55	0.585187488394937	1.0	0	0	1.1471178663607686	0.6146521251670638	IDH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001648 abnormal apoptosis	1/55	0.585187488394937	1.0	0	0	1.1471178663607686	0.6146521251670638	GPX4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011109 lethality throughout fetal growth and development, incomplete penetrance	3/191	0.5858170470647901	1.0	0	0	0.990965696070821	0.5299166708762706	POLE4;NPM1;YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001785 edema	4/258	0.5867812519859523	1.0	0	0	0.978162521702981	0.521461553620001	RAB2A;RANBP1;USP1;YBX1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008495 decreased IgG1 level	2/124	0.5874901960467169	1.0	0	0	1.0176045588684235	0.5412595102097472	HELLS;MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002111 abnormal tail morphology	2/124	0.5874901960467169	1.0	0	0	1.0176045588684235	0.5412595102097472	RPL38;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004613 fusion of vertebral arches	1/56	0.5917803771808989	1.0	0	0	1.1266336187471837	0.59105418817218	CBX5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002063 abnormal learning/memory/conditioning	1/56	0.5917803771808989	1.0	0	0	1.1266336187471837	0.59105418817218	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002797 increased thigmotaxis	1/56	0.5917803771808989	1.0	0	0	1.1266336187471837	0.59105418817218	MYG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010403 atrial septal defect	1/56	0.5917803771808989	1.0	0	0	1.1266336187471837	0.59105418817218	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008572 abnormal Purkinje cell dendrite morphology	1/56	0.5917803771808989	1.0	0	0	1.1266336187471837	0.59105418817218	CCND2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008083 decreased single-positive T cell number	1/56	0.5917803771808989	1.0	0	0	1.1266336187471837	0.59105418817218	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000550 abnormal forelimb morphology	1/56	0.5917803771808989	1.0	0	0	1.1266336187471837	0.59105418817218	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001924 infertility	2/125	0.5918693706456234	1.0	0	0	1.0094637223974765	0.5294327582484046	PCNA;CBX3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001566 increased circulating phosphate level	1/57	0.5982688057712996	1.0	0	0	1.1068681166638994	0.5686148852190931	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002023 increased B cell derived lymphoma incidence	1/57	0.5982688057712996	1.0	0	0	1.1068681166638994	0.5686148852190931	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002188 small heart	1/57	0.5982688057712996	1.0	0	0	1.1068681166638994	0.5686148852190931	KDM1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009936 abnormal dendritic spine morphology	1/57	0.5982688057712996	1.0	0	0	1.1068681166638994	0.5686148852190931	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002953 thick ventricular wall	1/57	0.5982688057712996	1.0	0	0	1.1068681166638994	0.5686148852190931	LSM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004819 decreased skeletal muscle mass	1/57	0.5982688057712996	1.0	0	0	1.1068681166638994	0.5686148852190931	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002133 abnormal respiratory system physiology	1/58	0.6046544240812114	1.0	0	0	1.0877841836179702	0.5472622473771931	HAT1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003229 abnormal vitelline vasculature morphology	2/129	0.6090395646370117	1.0	0	0	0.978162521702981	0.4850434517587247	NPM1;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006380 abnormal spermatid morphology	2/129	0.6090395646370117	1.0	0	0	0.978162521702981	0.4850434517587247	HSPA4;USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000220 increased monocyte cell number	2/129	0.6090395646370117	1.0	0	0	0.978162521702981	0.4850434517587247	POLE4;NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003641 small lung	1/59	0.6109388560446468	1.0	0	0	1.0693471635566487	0.5269297938919895	KDM1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005431 decreased oocyte number	1/59	0.6109388560446468	1.0	0	0	1.0693471635566487	0.5269297938919895	USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005466 abnormal T-helper 2 physiology	1/59	0.6109388560446468	1.0	0	0	1.0693471635566487	0.5269297938919895	CBX5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005018 decreased T cell number	3/199	0.6136193244813591	1.0	0	0	0.9511278791433508	0.4645123432411101	DKC1;ARHGDIA;RPL22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009141 increased prepulse inhibition	1/60	0.6171237001002169	1.0	0	0	1.0515247108307046	0.5075560344746267	NPM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000780 abnormal corpus callosum morphology	1/60	0.6171237001002169	1.0	0	0	1.0515247108307046	0.5075560344746267	CANX
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004994 abnormal brain wave pattern	1/60	0.6171237001002169	1.0	0	0	1.0515247108307046	0.5075560344746267	KDM1A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001392 abnormal locomotor behavior	2/131	0.6174168980059606	1.0	0	0	0.9632287427456836	0.464479300372724	MYG1;TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000137 abnormal vertebrae morphology	2/132	0.6215537161100944	1.0	0	0	0.9559315553006406	0.4545769448267607	HAT1;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001433 polyphagia	1/61	0.6232105294718999	1.0	0	0	1.0342866008170866	0.4890840241540511	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000150 abnormal rib morphology	2/133	0.625656024584874	1.0	0	0	0.948744099997628	0.4449178533679281	RPL38;H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001719 absent vitelline blood vessels	1/62	0.6292008926241992	1.0	0	0	1.0176045588684235	0.4714609638076042	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001431 abnormal eating behavior	1/62	0.6292008926241992	1.0	0	0	1.0176045588684235	0.4714609638076042	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008209 decreased pre-B cell number	1/62	0.6292008926241992	1.0	0	0	1.0176045588684235	0.4714609638076042	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008078 increased CD8-positive, alpha-beta T cell number	2/134	0.6297238743796955	1.0	0	0	0.9416639201468996	0.4354949388494104	HELLS;NDUFB8
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010123 increased bone mineral content	3/204	0.6303487968464679	1.0	0	0	0.92781592132121	0.42817031639803177	RRM2;RBBP4;NUP62
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001923 reduced female fertility	4/274	0.6340492390663822	1.0	0	0	0.921043542333464	0.4196538381432277	ARHGDIA;USP1;EIF4H;RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002135 abnormal kidney morphology	4/274	0.6340492390663822	1.0	0	0	0.921043542333464	0.4196538381432277	HELLS;DKC1;ARHGDIA;NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001732 postnatal growth retardation	10/677	0.6344961481363374	1.0	0	0	0.9319273655811264	0.4239561831546986	POLE4;RANBP1;VCP;LIG1;PSME3;HP1BP3;EIF4H;RPL38;HMGB1;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001222 epidermal hyperplasia	1/63	0.6350963135691167	1.0	0	0	1.001452105553052	0.4546378415491734	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001539 decreased caudal vertebrae number	1/63	0.6350963135691167	1.0	0	0	1.001452105553052	0.4546378415491734	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004984 increased osteoclast cell number	1/63	0.6350963135691167	1.0	0	0	1.001452105553052	0.4546378415491734	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005621 abnormal cell physiology	4/275	0.6368853793427565	1.0	0	0	0.9176942930886148	0.4140320760201723	DKC1;DAD1;RPS6;MAD2L1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002722 abnormal immune system organ morphology	1/64	0.6408982924148348	1.0	0	0	0.9858044164037856	0.43856910965159374	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005221 abnormal rostral-caudal axis patterning	1/64	0.6408982924148348	1.0	0	0	0.9858044164037856	0.43856910965159374	WLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004924 abnormal behavior	7/481	0.6429247407492678	1.0	0	0	0.9181712651744198	0.4055815944324187	EEF1B2;KDM1A;NUP62;RRS1;LSM1;BZW1;UCHL5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010097 abnormal retinal blood vessel morphology	1/65	0.6466083055956433	1.0	0	0	0.970638194612958	0.4232123938310781	HDAC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009454 impaired contextual conditioning behavior	1/65	0.6466083055956433	1.0	0	0	0.970638194612958	0.4232123938310781	HSPA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000520 absent kidney	1/66	0.652227806245282	1.0	0	0	0.9559315553006406	0.4085282305691236	H13
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001701 incomplete embryo turning	1/66	0.652227806245282	1.0	0	0	0.9559315553006406	0.4085282305691236	DAD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002703 abnormal renal tubule morphology	1/66	0.652227806245282	1.0	0	0	0.9559315553006406	0.4085282305691236	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005419 decreased circulating serum albumin level	2/140	0.6534110614962572	1.0	0	0	0.9013068949977469	0.3835501134063163	ARHGDIA;RCC2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008770 decreased survivor rate	3/212	0.6560631128774871	1.0	0	0	0.8928039997619189	0.3763153556435015	MSH2;TOMM5;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003723 abnormal long bone morphology	1/67	0.6577582246977519	1.0	0	0	0.9416639201468996	0.3944798294160609	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008535 enlarged lateral ventricles	1/67	0.6577582246977519	1.0	0	0	0.9416639201468996	0.3944798294160609	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009230 abnormal sperm head morphology	1/67	0.6577582246977519	1.0	0	0	0.9416639201468996	0.3944798294160609	GPX4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0013294 prenatal lethality prior to heart atrial septation	1/67	0.6577582246977519	1.0	0	0	0.9416639201468996	0.3944798294160609	RBBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005312 pericardial effusion	1/68	0.6632009687733711	1.0	0	0	0.92781592132121	0.3810328580498525	GLRX3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000572 abnormal autopod morphology	1/68	0.6632009687733711	1.0	0	0	0.92781592132121	0.3810328580498525	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001861 lung inflammation	2/144	0.6685231287775418	1.0	0	0	0.8762705923589205	0.3528603969653733	DKC1;TOMM5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000273 overriding aortic valve	1/69	0.6685574239819518	1.0	0	0	0.91436931376583	0.3681552474564005	SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005011 increased eosinophil cell number	1/69	0.6685574239819518	1.0	0	0	0.91436931376583	0.3681552474564005	TOMM5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005566 decreased blood urea nitrogen level	1/70	0.6738289540419349	1.0	0	0	0.9013068949977469	0.3558170145674747	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001303 abnormal lens morphology	3/218	0.6744922765509389	1.0	0	0	0.8682314126125084	0.34190523603906153	UQCRB;HDAC1;LSM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001286 abnormal eye development	1/71	0.6790169012536689	1.0	0	0	0.8886124316879194	0.343990101162691	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002100 abnormal tooth morphology	1/71	0.6790169012536689	1.0	0	0	0.8886124316879194	0.343990101162691	RBBP7
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008428 abnormal spatial working memory	1/71	0.6790169012536689	1.0	0	0	0.8886124316879194	0.343990101162691	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001293 anophthalmia	2/148	0.6830995929163826	1.0	0	0	0.8525876033762472	0.3249335946629076	NPM1;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004816 abnormal class switch recombination	1/72	0.684122586825106	1.0	0	0	0.8762705923589205	0.3326482272284628	MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004215 abnormal myocardial fiber physiology	1/72	0.684122586825106	1.0	0	0	0.8762705923589205	0.3326482272284628	GLRX3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005564 increased hemoglobin content	1/72	0.684122586825106	1.0	0	0	0.8762705923589205	0.3326482272284628	HMGB3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005169 abnormal male meiosis	1/72	0.684122586825106	1.0	0	0	0.8762705923589205	0.3326482272284628	HSP90AA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000585 kinked tail	3/222	0.6863699980125578	1.0	0	0	0.8525876033762472	0.32086148943032056	POLE4;RPL31;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009404 centrally nucleated skeletal muscle fibers	1/73	0.6891473109345109	1.0	0	0	0.8642668856142777	0.3217667575752807	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002175 decreased brain weight	1/73	0.6891473109345109	1.0	0	0	0.8642668856142777	0.3217667575752807	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005293 impaired glucose tolerance	4/296	0.6931083105638907	1.0	0	0	0.8525876033762472	0.31253218493018703	CCND2;MMGT2;RPS6;NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000929 open neural tube	2/151	0.6936853263339621	1.0	0	0	0.8356487768191031	0.30562754429519456	GLRX3;TMED2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002183 gliosis	1/74	0.6940923535163872	1.0	0	0	0.8525876033762472	0.3113225791608979	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006359 absent startle reflex	1/74	0.6940923535163872	1.0	0	0	0.8525876033762472	0.3113225791608979	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005166 decreased susceptibility to injury	1/75	0.6989589740599537	1.0	0	0	0.8412197686645637	0.3012939901600489	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004953 decreased spleen weight	1/76	0.7037484125353014	1.0	0	0	0.8301510874979247	0.2916605970888808	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008143 abnormal dendrite morphology	1/76	0.7037484125353014	1.0	0	0	0.8301510874979247	0.2916605970888808	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003084 abnormal skeletal muscle fiber morphology	1/76	0.7037484125353014	1.0	0	0	0.8301510874979247	0.2916605970888808	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001386 abnormal maternal nurturing	1/76	0.7037484125353014	1.0	0	0	0.8301510874979247	0.2916605970888808	KHDRBS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001146 abnormal testis morphology	2/155	0.70734477973121	1.0	0	0	0.8140836470947391	0.28186593356335515	RPL31;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008498 decreased IgG3 level	1/77	0.7084618890886637	1.0	0	0	0.8193699045434062	0.2824032219927244	MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010067 increased red blood cell distribution width	1/77	0.7084618890886637	1.0	0	0	0.8193699045434062	0.2824032219927244	DDOST
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001787 pericardial edema	1/77	0.7084618890886637	1.0	0	0	0.8193699045434062	0.2824032219927244	TCEA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011396 abnormal sleep behavior	1/77	0.7084618890886637	1.0	0	0	0.8193699045434062	0.2824032219927244	NPM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000921 demyelination	1/77	0.7084618890886637	1.0	0	0	0.8193699045434062	0.2824032219927244	CANX
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000703 abnormal thymus morphology	1/77	0.7084618890886637	1.0	0	0	0.8193699045434062	0.2824032219927244	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008396 abnormal osteoclast differentiation	1/78	0.7131006047157911	1.0	0	0	0.8088651621774651	0.27350381617603736	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008596 increased circulating interleukin-6 level	1/78	0.7131006047157911	1.0	0	0	0.8088651621774651	0.27350381617603736	LSM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009788 increased susceptibility to bacterial infection induced morbidity/mortality	1/78	0.7131006047157911	1.0	0	0	0.8088651621774651	0.27350381617603736	ADH5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005554 decreased circulating creatinine level	1/79	0.7176657415803493	1.0	0	0	0.7986263626562313	0.2649453813889709	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005016 decreased lymphocyte cell number	2/159	0.720493510070836	1.0	0	0	0.793603555343928	0.2601582216283961	POLE4;DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000194 increased circulating calcium level	1/80	0.7221584631812871	1.0	0	0	0.7886435331230285	0.2567118975399671	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005459 decreased percent body fat/body weight	1/80	0.7221584631812871	1.0	0	0	0.7886435331230285	0.2567118975399671	PCNA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002640 reticulocytosis	1/81	0.7265799145707719	1.0	0	0	0.7789071932079292	0.24878825611411545	LIG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000433 microcephaly	1/81	0.7265799145707719	1.0	0	0	0.7789071932079292	0.24878825611411545	SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000759 abnormal skeletal muscle morphology	1/81	0.7265799145707719	1.0	0	0	0.7789071932079292	0.24878825611411545	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0006036 abnormal mitochondrial physiology	1/81	0.7265799145707719	1.0	0	0	0.7789071932079292	0.24878825611411545	GPX4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000445 short snout	2/162	0.7300262836505069	1.0	0	0	0.7789071932079292	0.24510241888629536	RPL38;BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000183 decreased circulating LDL cholesterol level	1/82	0.7309312227193775	1.0	0	0	0.7694083249980765	0.24116019868121594	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001242 hyperkeratosis	1/82	0.7309312227193775	1.0	0	0	0.7694083249980765	0.24116019868121594	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002497 increased IgE level	1/82	0.7309312227193775	1.0	0	0	0.7694083249980765	0.24116019868121594	ASF1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003402 decreased liver weight	1/82	0.7309312227193775	1.0	0	0	0.7694083249980765	0.24116019868121594	EIF3M
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003131 increased erythrocyte cell number	1/82	0.7309312227193775	1.0	0	0	0.7694083249980765	0.24116019868121594	HMGB3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001762 polyuria	1/82	0.7309312227193775	1.0	0	0	0.7694083249980765	0.24116019868121594	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002753 dilated heart left ventricle	1/82	0.7309312227193775	1.0	0	0	0.7694083249980765	0.24116019868121594	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000955 abnormal spinal cord morphology	1/83	0.7352134971309557	1.0	0	0	0.7601383451788226	0.2338142599378153	CANX
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008844 decreased subcutaneous adipose tissue amount	1/83	0.7352134971309557	1.0	0	0	0.7601383451788226	0.2338142599378153	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000877 abnormal Purkinje cell morphology	1/83	0.7352134971309557	1.0	0	0	0.7601383451788226	0.2338142599378153	CCND2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001921 reduced fertility	2/165	0.7392824983693391	1.0	0	0	0.7647452442405124	0.2310105419712486	POLE4;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000154 rib fusion	1/84	0.7394278295195136	1.0	0	0	0.7510890791647891	0.2267377160972032	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005294 abnormal heart ventricle morphology	1/84	0.7394278295195136	1.0	0	0	0.7510890791647891	0.2267377160972032	YWHAE
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001154 seminiferous tubule degeneration	1/84	0.7394278295195136	1.0	0	0	0.7510890791647891	0.2267377160972032	USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000062 increased bone mineral density	2/166	0.7423072902912843	1.0	0	0	0.7601383451788226	0.2265151333566167	KHDRBS1;HAT1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001716 abnormal placenta labyrinth morphology	1/85	0.7435752944801229	1.0	0	0	0.7422527370569679	0.2199185361983163	HSP90AB1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003921 abnormal heart left ventricle morphology	1/85	0.7435752944801229	1.0	0	0	0.7422527370569679	0.2199185361983163	YWHAE
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001823 thymus hypoplasia	2/167	0.74530208395851	1.0	0	0	0.7555866185609853	0.22211651974129692	HELLS;RPL22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003354 astrocytosis	1/86	0.7476569496987829	1.0	0	0	0.7336218912772358	0.21334533754301604	CANX
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002757 decreased vertical activity	2/169	0.7512024278089825	1.0	0	0	0.7466447650868908	0.21360022338544807	RAB2A;MYG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005633 increased circulating sodium level	1/87	0.7516738361059279	1.0	0	0	0.7251894557453135	0.20700734450291036	DDOST
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003638 abnormal response/metabolism to endogenous compounds	1/87	0.7516738361059279	1.0	0	0	0.7251894557453135	0.20700734450291036	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011108 embryonic lethality during organogenesis, incomplete penetrance	3/247	0.7533111159495106	1.0	0	0	0.7662933115365458	0.21707324583039525	POLE4;PCNA;GLRX3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001718 abnormal visceral yolk sac morphology	1/88	0.7556269783154013	1.0	0	0	0.7169486664754804	0.20089435008497544	PTBP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005329 abnormal myocardium layer morphology	1/88	0.7556269783154013	1.0	0	0	0.7169486664754804	0.20089435008497544	BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002942 decreased circulating alanine transaminase level	1/88	0.7556269783154013	1.0	0	0	0.7169486664754804	0.20089435008497544	ATPIF1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002962 increased urine protein level	1/88	0.7556269783154013	1.0	0	0	0.7169486664754804	0.20089435008497544	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002743 glomerulonephritis	1/89	0.7595173847822604	1.0	0	0	0.7088930634813738	0.19499668056265898	RPL22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001876 decreased inflammatory response	1/89	0.7595173847822604	1.0	0	0	0.7088930634813738	0.19499668056265898	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000160 kyphosis	2/173	0.7626514873903197	1.0	0	0	0.7293813023103153	0.19762886763256074	HELLS;VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003203 increased neuron apoptosis	1/90	0.7633460478830882	1.0	0	0	0.7010164738871364	0.1893051627236466	G3BP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002874 decreased hemoglobin content	2/178	0.776319574136309	1.0	0	0	0.7088930634813738	0.17948535868844848	DKC1;MCM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001505 hunched posture	1/94	0.7780625748055959	1.0	0	0	0.6711859856366199	0.16843300066897698	MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000746 weakness	1/94	0.7780625748055959	1.0	0	0	0.6711859856366199	0.16843300066897698	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011939 increased food intake	1/94	0.7780625748055959	1.0	0	0	0.6711859856366199	0.16843300066897698	NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001513 limb grasping	3/258	0.7789132132217756	1.0	0	0	0.7336218912772358	0.1832995724808757	HSPA4;ANP32E;TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000208 decreased hematocrit	2/179	0.7789694052125947	1.0	0	0	0.7049327670373439	0.17608057968095495	LIG1;MCM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001688 abnormal somite development	1/95	0.7815968696964866	1.0	0	0	0.6641208699983397	0.16365013000554135	TFAM
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003059 decreased insulin secretion	1/95	0.7815968696964866	1.0	0	0	0.6641208699983397	0.16365013000554135	RPS6
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002833 increased heart weight	2/181	0.7841868837289167	1.0	0	0	0.6971434546943898	0.16948109168108122	RCC2;RPA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001258 decreased body length	5/412	0.7848126043636954	1.0	0	0	0.7656733331291538	0.18553054290360024	POLE4;CBX5;OLA1;EIF4H;RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002114 abnormal axial skeleton morphology	1/96	0.7850750561017006	1.0	0	0	0.6572029442691903	0.15902730868949735	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005202 lethargy	1/96	0.7850750561017006	1.0	0	0	0.6572029442691903	0.15902730868949735	HMGB1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000691 enlarged spleen	4/338	0.7862835698832221	1.0	0	0	0.7466447650868908	0.1795216065436442	NPM1;LIG1;DKC1;MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002675 asthenozoospermia	2/184	0.7918106723687106	1.0	0	0	0.6857769853243725	0.1600829555508387	HSPA4;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005669 increased circulating leptin level	1/98	0.7918666413245811	1.0	0	0	0.6437906392841047	0.1502364536866752	NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001155 arrest of spermatogenesis	1/98	0.7918666413245811	1.0	0	0	0.6437906392841047	0.1502364536866752	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000280 thin ventricular wall	1/99	0.7951817742330888	1.0	0	0	0.6372877035337604	0.1460564914950354	YWHAE
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002110 abnormal digit morphology	1/99	0.7951817742330888	1.0	0	0	0.6372877035337604	0.1460564914950354	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000221 decreased leukocyte cell number	2/186	0.7967606119400009	1.0	0	0	0.6784030392456158	0.15413385349195322	POLE4;DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011089 perinatal lethality, complete penetrance	3/269	0.8022952601971134	1.0	0	0	0.7036224830837428	0.154992964250408	YWHAE;HAT1;G3BP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010025 decreased total body fat amount	6/498	0.8044489686643005	1.0	0	0	0.7601383451788226	0.1654043912616027	EEF1B2;NUP62;ATPIF1;EIF4H;RAD23B;MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004201 fetal growth retardation	1/102	0.8048146541762169	1.0	0	0	0.6185439475474732	0.13431265623367356	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001360 abnormal social investigation	1/102	0.8048146541762169	1.0	0	0	0.6185439475474732	0.13431265623367356	MYG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003960 increased lean body mass	3/271	0.8063168629301394	1.0	0	0	0.6984296972307262	0.1503568860823842	PCNA;KARS;NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003675 kidney cysts	1/103	0.8079241749745817	1.0	0	0	0.612538666503323	0.13064657604226407	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009890 cleft secondary palate	1/104	0.8109843110005591	1.0	0	0	0.6066488716330988	0.12709692447581344	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010402 ventricular septal defect	2/193	0.8132757713736041	1.0	0	0	0.6537977476667594	0.13513020367030654	YWHAE;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002882 abnormal neuron morphology	1/105	0.8139958439749739	1.0	0	0	0.6008712633318313	0.12365931721464987	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010412 atrioventricular septal defect	1/105	0.8139958439749739	1.0	0	0	0.6008712633318313	0.12365931721464987	SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005668 decreased circulating leptin level	1/105	0.8139958439749739	1.0	0	0	0.6008712633318313	0.12365931721464987	KHDRBS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001954 respiratory distress	2/194	0.8155349886956393	1.0	0	0	0.6504276561839409	0.1326293233915806	BSG;OLA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002144 abnormal B cell differentiation	1/106	0.8169595435451605	1.0	0	0	0.5952026665079461	0.1203295658905916	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005015 increased T cell number	1/106	0.8169595435451605	1.0	0	0	0.5952026665079461	0.1203295658905916	NDUFB8
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000706 small thymus	1/106	0.8169595435451605	1.0	0	0	0.5952026665079461	0.1203295658905916	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008211 decreased mature B cell number	1/106	0.8169595435451605	1.0	0	0	0.5952026665079461	0.1203295658905916	MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005092 decreased double-positive T cell number	1/107	0.819876167030905	1.0	0	0	0.589640024764881	0.11710366811748235	PSME3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001147 small testis	4/357	0.8203528676023591	1.0	0	0	0.7069073686256837	0.1399822954648888	HSP90AA1;CBX3;USP1;RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000564 syndactyly	1/108	0.82274645982082	1.0	0	0	0.584180394905947	0.11397779765702787	DAD1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002376 abnormal dendritic cell physiology	1/109	0.8255711556225073	1.0	0	0	0.5788209417416723	0.11094829527850247	HSP90AA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001516 abnormal motor coordination/balance	1/110	0.8283509766612028	1.0	0	0	0.5735589331803843	0.10801166019739514	CANX
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002639 micrognathia	1/111	0.8310866334090973	1.0	0	0	0.5683917355841647	0.10516454233895682	SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011087 neonatal lethality, complete penetrance	6/517	0.8316291201124237	1.0	0	0	0.7322028934217673	0.1349953004590808	HELLS;NPM1;HAT1;HMGB1;YBX1;LMNB2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000607 abnormal hepatocyte morphology	1/114	0.8390355582410199	1.0	0	0	0.5534340583319497	0.09712889020936563	RPS6
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000416 sparse hair	1/114	0.8390355582410199	1.0	0	0	0.5534340583319497	0.09712889020936563	MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004901 decreased male germ cell number	1/114	0.8390355582410199	1.0	0	0	0.5534340583319497	0.09712889020936563	POLE4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002082 postnatal lethality	2/206	0.8407993550479081	1.0	0	0	0.612538666503323	0.10621556858243657	CANX;BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002792 abnormal retinal vasculature morphology	1/115	0.8416014434125854	1.0	0	0	0.5486215882594979	0.09460909171234036	HDAC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011940 decreased food intake	1/118	0.8490570190495235	1.0	0	0	0.5346735817783244	0.08748806858747239	DENR
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009642 abnormal blood homeostasis	1/120	0.8538320028576691	1.0	0	0	0.5257623554153523	0.08308139984770907	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003633 abnormal nervous system physiology	1/123	0.8607135998393025	1.0	0	0	0.5129388833320511	0.0769374812372663	TFAM
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005561 increased mean corpuscular hemoglobin	1/123	0.8607135998393025	1.0	0	0	0.5129388833320511	0.0769374812372663	FAM53B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002092 abnormal eye morphology	2/217	0.8611660497821749	1.0	0	0	0.5814883193533851	0.08691385905248751	RRM1;RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0010024 increased total body fat amount	2/218	0.8628945065723181	1.0	0	0	0.5788209417416723	0.08535457744751329	DKC1;NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001805 decreased IgG level	1/126	0.8672721799514244	1.0	0	0	0.5007260527765259	0.07130460088209796	MSH2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002064 seizures	1/127	0.8693892251150206	1.0	0	0	0.496783327951514	0.06953195756314423	VCP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005333 decreased heart rate	1/128	0.8714726071334923	1.0	0	0	0.4929022082018927	0.06780897396325254	GCSH
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000414 alopecia	1/129	0.8735228595197526	1.0	0	0	0.4890812608514905	0.06613404725606717	HELLS
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002644 decreased circulating triglyceride level	2/226	0.8760291112058679	1.0	0	0	0.5583317048658608	0.07389852691312161	HELLS;LSM14A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005508 abnormal skeleton morphology	1/131	0.8775260681066068	1.0	0	0	0.4816143713728418	0.06292225146982504	EIF4H
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001510 abnormal coat appearance	1/131	0.8775260681066068	1.0	0	0	0.4816143713728418	0.06292225146982504	EIF2S2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000598 abnormal liver morphology	2/233	0.8865622090892177	1.0	0	0	0.5415577909857706	0.06520571457870172	BSG;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001405 impaired coordination	4/405	0.8869049214175675	1.0	0	0	0.6231257545663434	0.07478599126343499	POLE4;VCP;ANP32E;TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0004952 increased spleen weight	1/136	0.8869900839215472	1.0	0	0	0.463907960660605	0.05563252740741003	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000222 decreased neutrophil cell number	1/136	0.8869900839215472	1.0	0	0	0.463907960660605	0.05563252740741003	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011086 postnatal lethality, incomplete penetrance	7/643	0.8873635643436585	1.0	0	0	0.686843512517723	0.0820781430077868	HELLS;CBX3;BSG;CANX;HP1BP3;USP1;SMARCA4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008567 decreased interferon-gamma secretion	1/143	0.8990273384045899	1.0	0	0	0.4411991793695264	0.046962050331616566	HSP90AA1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002060 abnormal skin morphology	1/144	0.9006392502508977	1.0	0	0	0.4381352961794602	0.04585107331289509	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000562 polydactyly	1/145	0.9022255091685344	1.0	0	0	0.4351136734471881	0.044769185250592564	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005331 insulin resistance	1/147	0.9053226893328328	1.0	0	0	0.4291937595227365	0.042689257725233916	NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001175 abnormal lung morphology	1/148	0.9068344053899128	1.0	0	0	0.4262938016881235	0.04168958117782258	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002059 abnormal seminal vesicle morphology	1/148	0.9068344053899128	1.0	0	0	0.4262938016881235	0.04168958117782258	FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000689 abnormal spleen morphology	2/251	0.9099623386131496	1.0	0	0	0.5027209772895799	0.047432763063615414	DKC1;EIF2S2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001364 decreased anxiety-related response	1/151	0.9112266952987588	1.0	0	0	0.4178243884095515	0.03884244695443193	MYG1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001394 circling	1/151	0.9112266952987588	1.0	0	0	0.4178243884095515	0.03884244695443193	RAD23B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005560 decreased circulating glucose level	3/343	0.911259237181826	1.0	0	0	0.5518205479578041	0.05127950201079587	RPA1;BAZ1B;NPM3
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008874 decreased physiological sensitivity to xenobiotic	1/152	0.9126444252478804	1.0	0	0	0.4150755437489623	0.037941612072590336	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001402 hypoactivity	5/514	0.9130432580775396	1.0	0	0	0.6137303759712284	0.05583229164401594	MYG1;KDM1A;NUCKS1;UCHL5;MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005179 decreased circulating cholesterol level	2/254	0.9133942510212132	1.0	0	0	0.496783327951514	0.045002445313568666	HELLS;BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002891 increased insulin sensitivity	1/155	0.9167636117162646	1.0	0	0	0.4070418235473695	0.03537422381020156	RPS6
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011967 increased or absent threshold for auditory brainstem response	3/354	0.9217142412471956	1.0	0	0	0.5346735817783244	0.04358661018887361	COX4I1;RPL38;LSM14A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005559 increased circulating glucose level	1/161	0.924430086097022	1.0	0	0	0.39187256304249857	0.030792505237347438	NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001891 hydrocephaly	1/163	0.9268257951389384	1.0	0	0	0.3870643107352287	0.029412883178199064	RPL31
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001922 reduced male fertility	2/268	0.9278497529267029	1.0	0	0	0.4708319600734498	0.03525846955018761	GPX4;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000702 enlarged lymph nodes	1/164	0.9279951041665516	1.0	0	0	0.3847041624990383	0.028748488840674068	DDOST
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008489 slow postnatal weight gain	1/168	0.9324889959267262	1.0	0	0	0.3755445395823945	0.026249785244316173	TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001926 female infertility	3/367	0.9326157475075436	1.0	0	0	0.5157341905981657	0.035978653325390984	CCND2;BSG;FKBP4
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001914 hemorrhage	2/275	0.9341947825698492	1.0	0	0	0.4588471465443074	0.031233870190978112	EIF4H;EIF2S2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001393 ataxia	2/275	0.9341947825698492	1.0	0	0	0.4588471465443074	0.031233870190978112	POLE4;CANX
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001260 increased body weight	2/278	0.9367494849749448	1.0	0	0	0.4538955586319589	0.029657259427814775	NUCKS1;TARDBP
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001552 increased circulating triglyceride level	1/178	0.9425379245348591	1.0	0	0	0.3544465317406869	0.0209758346280917	LSM14A
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002079 increased circulating insulin level	1/180	0.944361112244922	1.0	0	0	0.3505082369435682	0.020065423002599756	NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003179 thrombocytopenia	1/184	0.9478362877364304	1.0	0	0	0.34288849266218624	0.01836973114157523	DKC1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000063 decreased bone mineral density	3/389	0.9479373861863124	1.0	0	0	0.4865667042404289	0.026015177913963676	HELLS;KDM1A;USP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011088 neonatal lethality, incomplete penetrance	2/293	0.9481749137902552	1.0	0	0	0.4306585846405616	0.02291805020578775	OLA1;TOMM5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001399 hyperactivity	5/567	0.948304996621612	1.0	0	0	0.5563622808628066	0.029531210297068764	EEF1B2;CCND2;COX4I1;RRS1;BZW1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000266 abnormal heart morphology	3/391	0.9491567785060674	1.0	0	0	0.4840778719936748	0.025259807875125943	YWHAE;VCP;BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008075 decreased CD4-positive, alpha beta T cell number	1/186	0.9494918559754338	1.0	0	0	0.3392015196228079	0.017580246917784204	RPL22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000218 increased leukocyte cell number	1/186	0.9494918559754338	1.0	0	0	0.3392015196228079	0.017580246917784204	NPM1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005565 increased blood urea nitrogen level	1/189	0.9518775023229744	1.0	0	0	0.33381736851768395	0.016463514262505287	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002151 abnormal neural tube morphology	1/190	0.9526474859015158	1.0	0	0	0.3320604349991699	0.016108365640511494	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0008079 decreased CD8-positive, alpha-beta T cell number	1/191	0.9534051870048876	1.0	0	0	0.3303218986902737	0.01576140706969813	RPL22
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002727 decreased circulating insulin level	2/301	0.953437064457862	1.0	0	0	0.4192125093012776	0.019988832549219227	RPS6;GOLGA7
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001489 decreased startle reflex	1/195	0.9563170262636744	1.0	0	0	0.323546064870986	0.014451444947996809	EEF1B2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002083 premature death	10/997	0.9574238323010876	1.0	0	0	0.6328132662973146	0.02753314176099276	MSH2;ARHGDIA;POLD1;RPA1;MCM3;UQCRFS1;KIF22;HMGB1;RAD23B;MCM2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003961 decreased lean body mass	3/407	0.9579976619742986	1.0	0	0	0.4650477836597711	0.01995517321113633	ATP5A1;EIF4H;EIF2S2
MGI_Mammalian_Phenotype_Level_4_2019	MP:0009763 increased sensitivity to induced morbidity/mortality	1/198	0.9583812065308488	1.0	0	0	0.3186438517668802	0.013545442126502206	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002451 abnormal macrophage physiology	1/199	0.9590474248852724	1.0	0	0	0.31704262638111697	0.013257059076555678	PARP1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002628 hepatic steatosis	1/206	0.9634225405697092	1.0	0	0	0.3062693332516615	0.01141257179370093	NUCKS1
MGI_Mammalian_Phenotype_Level_4_2019	MP:0003795 abnormal bone structure	2/323	0.965406866206024	1.0	0	0	0.390659335293141	0.01375341328426665	EEF1B2;NUP62
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000111 cleft palate	1/214	0.9678548655554432	1.0	0	0	0.2948200123824405	0.009632694131301741	RPL38
MGI_Mammalian_Phenotype_Level_4_2019	MP:0011085 postnatal lethality, complete penetrance	3/432	0.9689852368580624	1.0	0	0	0.4381352961794602	0.01380384798809474	VCP;RPL38;BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0005178 increased circulating cholesterol level	1/225	0.9730881393240896	1.0	0	0	0.2804065895548545	0.007649664430794879	ARHGDIA
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001406 abnormal gait	3/448	0.9745297215599458	1.0	0	0	0.4224876070301938	0.01090029061840633	POLE4;HELLS;CANX
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002412 increased susceptibility to bacterial infection	1/236	0.9774716044463624	1.0	0	0	0.2673367908891622	0.006091545929605596	ADH5
MGI_Mammalian_Phenotype_Level_4_2019	MP:0000745 tremors	1/355	0.996727615061936	1.0	0	0	0.1777224863375839	0.0005825300393975438	CANX
MGI_Mammalian_Phenotype_Level_4_2019	MP:0001265 decreased body size	8/1111	0.9971108069250859	1.0	0	0	0.4543041054894133	0.0013144720729862365	VCP;ARPC3;CANX;OLA1;EIF4H;TFAM;RPL38;BAZ1B
MGI_Mammalian_Phenotype_Level_4_2019	MP:0002169 no abnormal phenotype detected	13/1944	0.9999463976999732	1.0	0	0	0.4219080629876283	2.261584871221445e-05	CBX5;GPX4;NONO;RPL22;HMGB3;PRPF19;SMARCA4;HINT1;DKC1;HAT1;ANP32E;KPNB1;MCM2
